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1. Background 
Avoidable hospital readmissions have become a common and much-publicized 
issue in American health care, with research estimating that they waste billions of dollars 
every year.(National Quality Forum, 2010a) A 2009 study by Jencks et al. focused 
attention to the problem when it found that one-fifth of hospitalized Medicare patients 
were readmitted within 30 days, and that 90 percent of those readmissions were 
unplanned.(Jencks, Williams, & Coleman, 2009) Hospital groups have subsequently 
made them a top priority in their quality improvement efforts (HealthEast Care System, 
2010; Rennke et al., 2013; Schwartz, 2013) and the federal Medicare program has sought 
to reduce hospitalizations by issuing penalties to hospitals with unacceptable 30-day 
readmission rates.(Abelson, 2013; Rau, 2013) Medication problems have emerged in 
research as a driver of readmissions and a target for hospitals seeking to improve the 
quality of their care.(Bonnet-Zamponi et al., 2013; Kansagara et al., 2011; Morrissey, 
Morrissey, McElnay, Scott, & McConnell, 2003) Four of five elderly patients leaving 
Yale-New Haven Hospital experienced medication problems, according to a survey of 
377 patients, because they didn’t understand their revised prescription regimens, or 
because doctors prescribed the wrong drugs or doses or took their patients off drugs that 
were still needed.(Ziaeian, Araujo, Van Ness, & Horwitz, 2012) Patients’ struggles with 
managing their new prescription regimens have been associated with readmissions along 
with confusion among doctors in reconciling their patients’ new prescription regimens 
with the drugs they took before they were hospitalized.(Agency for Healthcare Research 
and Quality, 2012; National Quality Forum, 2010b)  A lack of access to affordable 
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medication has similarly been cited as a cause of adverse-drug events in patients that 
pushes them back into hospital care.(Silow-Carroll, Edwards, & Lashbrook, 2011) 
Estimates vary in terms of how many readmissions are due to medication issues, but one 
study found nearly one in five readmissions of elderly patients was due to adverse drug 
reactions, which are defined as “noxious and unintended” consequences of normal 
medication usage.(Teymoorian, Dutcher, & Woods, 2011) Another study found nearly 
one in four of these adverse reactions prompted hospital readmissions when only looking 
at seniors 80 and older.(M. Zhang et al., 2009) Examining the broader concept of 
“medication-related problems,” which includes not only adverse reactions but other 
issues such as drug overuse, another study associated these problems with nearly 4 in 10 
rehospitalizations in a sample population of elderly patients.(Bonnet-Zamponi et al., 
2013) 
Hospitals over the past decade have been encouraged by groups such as the Joint 
Commission to create medication reconciliation processes to make sure that changes in 
prescriptions during admissions don’t leave patients with harmful, inadequate or 
confusing drug regimens when they are discharged home or to another care 
setting.(Agency for Healthcare Research and Quality, 2012) Pharmacists have been 
engaged at more hospitals in discharge planning as well – often with the primary goal of 
reducing avoidable readmissions.(Anderegg, Wilkinson, Couldry, Grauer, & Howser, 
2014; Fera, Anderson, Kanel, & Ramusivich, 2014; Kirkham, Clark, Paynter, Lewis, & 
Duncan, 2014; Pal, Babbott, & Wilkinson, 2013)  Patient interviews have made it 
apparent that a pamphlet or 15 minutes of instructions when they are about to be 
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discharged from hospital care aren’t enough.(Robert Wood Johnson Foundation, 2013)  
While home visits by nurses(HealthEast Care System, 2010) and even 
firefighters(Smetanka, 2014) might be effective alternatives, these can be expensive and 
resource-intensive solutions. A challenge, as a result, is identifying which patients are at 
greatest risk of readmissions and would benefit most from these sorts of prevention 
strategies.(Kansagara et al., 2011; Morrissey et al., 2003; Walsh & Hripcsak, 2014) 
Therefore, there is a need to identify medication-related predictors of hospital 
readmissions.  
Several medication measures have been studied in conjunction with hospital 
readmissions. One potential predictor of hospital readmission is polypharmacy, a simple 
count of the prescriptions in patients’ regimens, and whether the number of drugs 
elevates readmission risk. Results of studies differ on whether polypharmacy is a risk 
factor, and studies that have found a problem have varied in terms of the number of drugs 
that separates patients into high- and low-risk groups.(Morandi et al., 2013; Sganga et al., 
2014) Other studies have looked at the role of Potentially Inappropriate Medications 
(PIM) to determine if drugs with known risks in the elderly are driving readmissions. 
Findings so far have varied from finding an association,(Price, Holman, Sanfilippo, & 
Emery, 2014a) or no association,(Borenstein et al., 2013) or an association only in the 
context with polypharmacy.(Sehgal et al., 2013) A third target for research on 
medication-related readmission risks is the Medication Regimen Complexity Index 
(MRCI),(George, Phun, Bailey, Kong, & Stewart, 2004) a measure of patients’ regimens 
based on the complexity of the drugs by their instructions, dosing or routes. At least one 
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study attempted an automated approach to scoring this measurement,(McDonald et al., 
2013) while another found a relationship between MRCI and readmissions.(Willson, 
Greer, & Weeks, 2014)  
Dierich hypothesized that a combination of all three measures (polypharmacy, 
PIM, and MRCI) could produce a more reliable indicator of readmission risk.(Dierich, 
2010) Using factor analysis, she constructed a composite measure called High Risk 
Medication Regimen (HRMR) that utilized all three medication indicators, and tested its 
predictive power against the actual readmission histories of 911 adults from 15 Medicare-
certified home health care agencies. A structural equation model using HRMR as a 
mediating variable was more predictive of readmissions than using comorbidity or any of 
the three components on their own as mediating variables. HRMR accounted for a unique 
variance of 10% in patients’ readmission risks as well as 20% of the comorbidity effect 
of readmission.(Dierich, 2010)  
A barrier to clinical utility of this discovery is the cumbersome, manual process 
used in the initial research to produce patient HRMR scores. The medications for the 911 
patients were described in generic text descriptions, and not standardized in a way that 
could be used for data analysis and clinical decision support. Health care is gradually 
moving toward standardized electronic health records (EHRs), though, with $30 billion in 
federal funds helping hospitals and health systems achieve a basic level of competency 
known as “meaningful use.”(Adler-Milstein et al., 2014) As of 2013, 59 percent of U.S. 
hospitals had achieved Stage 1 certification with their EHR systems, which requires them 
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to track patient medication lists and allow electronic prescription ordering.(Adler-
Milstein et al., 2014) 
2. Statement of Purpose 
The overall purpose of this study was to transform the concept of HRMR into an 
automated tool that could potentially be used in clinical care to assess patients’ 
medication-related rehospitalization risks. This was achieved by creating automated 
processes that convert non-standardized medication information into formatted data for 
analysis, and that calculate HRMR scores based on patients’ standardized drug data. The 
rapidly expanding use of EHRs will greatly increase the potential for the automated 
calculation of HRMRs and its possible use as a clinical decision support tool. 
 
3. Structure of Dissertation 
Three publishable papers for this dissertation describe the steps in the process for 
transforming the concept of HRMR from a manual process to an automated process.  The 
papers: (1) create an automated approach to deriving HRMR scores and testing its 
accuracy with the same home health care population Dierich used, (2) optimize the 
calculation of HRMR scores to maximize the algorithm’s sensitivity to readmissions and 
ready it for clinical utility, and (3) identify clusters of patients to determine if HRMR-
related readmission risks are more prevalent in certain demographic groups. 
All three studies used Outcome and Assessment Information Set (OASIS) and 
medication records for 911 adults from 15 Medicare-certified home health care agencies 
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that were used in the original Dierich study. OASIS data were obtained from electronic 
health records for the patients, all of whom were at least 65 and were admitted from the 
hospital to home health care in 2004. The data included demographic, environmental, 
support system, health and functional status, and health service utilization 
information.(Centers for Medicare and Medicaid Services (CMS), 2012b) Medication 
data included the medication names, doses, dose forms, frequencies and special 
instructions.(Dierich, 2010)  
The first study automated the algorithm by automatically mapping the medication 
data to RxNorm, a nomenclature created by the U.S. Library of Medicine (NLM) to 
match standardized drug terms with other commonly used names for drugs in medical 
records.(National Library of Medicine, 2013) HRMR scores were then calculated based 
on the standardized medication data. The automated algorithm was designed using 
RxNorm and NLM application programming interfaces, or APIs, for easy replication and 
application across different health care systems and databases. Results have been 
accepted for publication in the Journal of Biomedical Informatics and are available 
online.(Olson, Dierich, & Westra, 2014) 
The second study used odds ratio analyses, literature reviews and clinical 
judgments to adjust the scoring of patients’ HRMRs. Receiver Operating Characteristic 
(ROC) analysis evaluated whether these adjustments improved the predictive strength of 
the algorithm. The paper has been accepted and published in the Journal of Applied 
Clinical Informatics.(Olson, Dierich, Adam, & Westra, 2014) 
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The third study used unsupervised clustering to identify patient population 
subgroups. HRMR scores were then applied to these subgroups, and ROC and False 
Discovery Rate (FDR) analysis evaluated whether the predictive strength of the algorithm 
increased for a specific patient population subgroup. The paper has been formatted and 
submitted for publication in a peer-reviewed informatics journal. 
All three manuscripts are included in the subsequent chapters for this dissertation, 
and the formats are consistent with the instructions of the respective journals to which 
they have been submitted. Chapter five includes a summary of major findings from this 
project along with a unified reference list for the introduction, the three papers and the 
conclusion.  
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Objective: Create an automated algorithm for predicting elderly patients’ 
medication-related risks for readmission and validate it by comparing results with a 
manual analysis of the same patient population. 
Materials and Methods: Outcome and Assessment Information Set (OASIS) and 
medication data were reused from a previous, manual study of 911 patients from 15 
Medicare-certified home health care agencies. The medication data was converted into 
standardized drug codes using APIs managed by the National Library of Medicine 
(NLM), and then integrated in an automated algorithm that calculates patients’ high risk 
medication regime scores (HRMRs). A comparison of the results between algorithm and 
manual process was conducted to determine how frequently the HRMR scores were 
derived which are predictive of readmission. 
Results: HRMR scores are composed of polypharmacy (number of drugs), 
Potentially Inappropriate Medications (PIM) (drugs risky to the elderly), and Medication 
Regimen Complexity Index (MRCI) (complex dose forms, instructions or 
administration). The algorithm produced polypharmacy, PIM, and MRCI scores that 
matched with 99, 87 and 99 percent of the scores, respectively, from the manual analysis.  
Discussion: Imperfect match rates resulted from discrepancies in how drugs were 
classified and coded by the manual analysis vs. the automated algorithm. HRMR rules 
lack clarity, resulting in clinical judgments for manual coding that were difficult to 
replicate in the automated analysis.  
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Conclusion:  The high comparison rates for the three measures suggest that an 
automated clinical tool could use patients’ medication records to predict their risks of 
avoidable readmissions. 
 
Keywords: Rehospitalization, Avoidable Readmission, High Risk Medication 
Regimen, Home Health Care, Algorithm, RXNorm 
 
1. Introduction 
1.1. Background 
Avoidable hospital readmissions are indicators of “wasteful” health care 
spending(National Quality Forum, 2010a) and of poor quality care and discharge 
planning for patients. A 2003-2004 claims analysis found that a fifth of Medicare patients 
were rehospitalized within 30 days of initial discharges, and that 90% of those 
readmissions were unplanned.(Jencks et al., 2009)
 
 The cost to Medicare in 2004 alone 
was $17.4 billion, the analysis found, and the readmissions were associated with longer 
follow-up hospital stays. Estimates vary widely in terms of how many unplanned 
readmissions are avoidable,(van Walraven, Bennett, Jennings, Austin, & Forster, 2011) 
but all hospital stays expose patients to risks of delirium, infections and iatrogenic 
consequences of tests and procedures.(Allegranzi, 2011; Inouye, Schlesinger, & Lydon, 
1999) Identifying patients at greatest risk and offering them support to prevent 
readmissions has consequently become a top priority for hospitals – especially now that 
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the federal Medicare program financially penalizes hospitals with 30-day readmission 
rates deemed unacceptably high.(Abelson, 2013) 
Some health systems and hospitals have reported early success in identifying 
patients at risk for potentially avoidable readmissions(Donze, Aujesky, Williams, & 
Schnipper, 2013) and providing these at-risk patients with post-discharge home visits and 
other preventive care services.(Bonnet-Zamponi et al., 2013; HealthEast Care System, 
2010; Schwartz, 2013) However, one study concluded the evidence in favor of such post-
discharge programs remains weak(Rennke et al., 2013) and another concluded that 
systems to identify patients at greatest risk for readmissions have “performed 
poorly.”(Kansagara et al., 2011) Meanwhile, two-thirds of U.S. hospitals are paying 
federal penalties for having more readmissions than would be expected given their patient 
populations.(Rau, 2013) 
In the search for a better way to reduce readmissions, focusing on medications 
would seem to offer a promising target. A survey of 377 elderly patients discharged from 
Yale-New Haven Hospital found 81.4% of elderly patients experienced medication 
problems after hospital discharges because they didn’t understand changes to their drug 
regimens or because doctors erred in making prescriptions, setting doses, or telling 
patients to stop taking drugs they needed.(Ziaeian et al., 2012) Just the prescribing of 
medications with known risks that outweigh benefits for the elderly added an estimated 
$7 billion to U.S. healthcare expenditures in 2001.(Fu et al., 2007)  Recent research has 
evaluated whether readmissions are associated with polypharmacy (patients who take 
multiple medications)(Morandi et al., 2013; Sehgal et al., 2013; Sganga et al., 2014); 
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Potentially Inappropriate Medication (PIM, drugs known to be risky to the 
elderly)(Sehgal et al., 2013); or medication regimen complexity (drugs with complex 
dose forms, instructions and administration)(Schoonover, 2011; Willson et al., 2014). 
While research has demonstrated an association between polypharmacy and avoidable 
readmissions, at least one study failed to find a relationship.(Mansur, Weiss, & 
Beloosesky, 2008) PIM alone has not emerged as a meaningful indicator.(Sehgal et al., 
2013)  
Dierich hypothesized that these variables did not consistently predict readmission 
on their own, and used factor analysis to construct a measure called high risk medication 
regimens (HRMRs) that combined all three.(Dierich, 2010) A structural equation model 
using HRMR as a mediating variable was more predictive of readmissions than using 
comorbidity or any of the three components on their own as mediating variables. HRMRs 
accounted for a unique variance of 10% in patients’ readmission risks as well as 20% of 
the comorbidity effect of readmission.(Dierich, 2010) 
However, the manual process of deriving HRMR scores for this study was tedious 
and limited the utility of this discovery. Automation of this process is necessary for 
follow-up research to verify the predictive power of HRMRs, and for the potential 
development of a clinical tool that uses prescription data from electronic health records to 
assess patients' readmission risks. 
1.2. Objective 
This study seeks to advance Dierich’s discovery by developing an automated 
algorithm for determining HRMR scores – thereby determining which patients are at 
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greater risk for medication-related hospital readmissions and would benefit the most from 
medication management services. The specific aims are to: (1) map medication data 
automatically to RxNorm coding standards (2) create an automated algorithm that uses 
the coded medication data to calculate patient HRMR scores for easy replication and 
application across different health care systems and databases, and (3) test the 
algorithm’s accuracy by seeing if it derived the same HRMR scores that Dierich 
calculated through her manual analysis. 
2. Materials and Methods 
2.1. Data Set 
The data set developed in Dierich's study was utilized for this study. It contains 
Outcome and Assessment Information Set (OASIS) and medication data from 911 older 
adults from 15 Medicare-certified home health care agencies. Patients were 65 and older 
whose first episodes of home care took place after initial hospitalizations in 2004. Home 
care clinicians reviewed the medication records and validated their accuracy by observing 
the medications in patients’ homes. Only patients with complete OASIS and medication 
records were included in the data set. OASIS is a comprehensive assessment tool 
completed by home care clinicians to track conditions of patients at admission, various 
points during their episodes of care, and discharge.(Dierich, 2010) It is used to calculate 
outcome and risk factors of patients in Medicare-certified home care agencies, and 
includes demographic, environmental, support system, health and functional status, and 
health service utilization information.(Centers for Medicare and Medicaid Services 
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(CMS), 2012a) The medication data includes all prescribed and over-the-counter 
medications and contained the medication name, dose, frequency, dose forms, 
frequencies and special instructions. 
2.2. Coding Standard Definitions 
RxNorm: A standardized nomenclature for clinical drugs that is produced by the 
National Library of Medicine (NLM).(National Library of Medicine, 2013) RxNorm’s 
standardized naming conventions allow health systems, which might catalog drugs in 
different ways in their computer systems, to communicate efficiently and 
accurately.(Nelson, Zeng, Kilbourne, Powell, & Moore, 2011) 
RXCUI: A unique numerical identifier for clinical drugs and their concepts. 
Medications with the same RXCUIs are considered the same drugs with the same 
ingredients, strengths and dose forms. 
TTY: Term types (TTYs) are used along with RXCUIs to further identify generic 
and branded drug by their properties (ingredients, dose forms, etc.) Examples are shown 
in Table 1. 
 
Table 1: RXCUI Examples with Corresponding TTY types  
TTY 
TTY 
Name 
TTY Description
15
 RXCUI RXCUI String 
IN Ingredient 
A compound or moiety that 
gives the drug its distinctive 
clinical properties.  
2541 Cimetidine 
BN 
Brand 
Name 
A proprietary name for a 
family of products containing a 
specific active ingredient. 
152402 Tagamet 
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MIN 
Multiple 
Ingredients 
Two or more ingredients 
appearing together in a single 
drug preparation, created from 
SCDF. In rare cases when 
IN/PIN or PIN/PIN 
combinations of the same base 
ingredient exist, created from 
SCD. 
818150 
alginic acid / 
Cimetidine 
DF Dose Form Dose Form 316949 
Injectable 
Solution 
SCDF 
Semantic 
Clinical 
Drug Form 
Ingredient + Dose Form 371513 
Cimetidine 
Injectable 
Solution 
SCD 
Semantic 
Clinical 
Drug 
Ingredient + Strength + Dose 
Form 
309296 
Cimetidine 1.8 
MG/ML 
Injectable 
Solution 
SBD 
Semantic 
Branded 
Drug 
Ingredient + Strength + Dose 
Form + Brand Name 
205746 
Cimetidine 6 
MG/ML 
Injectable 
Solution 
[Tagamet] 
 
 
2.3. Tools used in Conjunction with Coding Standards 
RXNORM APIs: Online tools that convert drug descriptions from datasets into 
normalized RxNorm drug codes for research and analysis.(National Library of Medicine, 
2012) Examples from this study are in table 2. 
 
Table 2: Example Mapping Local Medications to RXCUI Values  
API Name Description Example API Calls  
Example 
Record(s) 
Returned 
approxMatch(term) 
Search by 
name to 
find the 
approxMatch(Cimetidine
) 
RXCUI: 2541 
SCORE: 100 
RANK: 1 
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closest 
RxNorm 
concepts 
 
RXCUI: 91215 
SCORE: 100 
RANK: 1 
getRXConceptProperties(
rxcui) 
Return the 
concept's 
properties 
getRXConceptProperties
(2541) 
STR:Cimetidine 
TTY: IN 
RXCUI: 2541 
getAllRelatedInfo(rxcui) 
Get all the 
related 
RxNorm 
concepts for 
a given 
RxNorm 
identifier 
getAllRelatedInfo(2541) 
STR: Tagamet 
TTY: BN 
RXCUI: 
152402 
 
STR: alginic 
acid / Cimetidin 
TTY: MIN 
RXCUI: 
818150 
 
STR: 
Cimetidine 6 
MG/ML 
Injectable 
Solution 
[Tagamet] 
TTY: SBD 
RXCUI: 
205746 
 
STR: 
Cimetidine 1.8 
MG/ML 
Injectable 
Solution 
TTY: SCD 
RXCUI: 
309296 
getAllConceptsByTTY(te
rmtypes) 
Return the 
RxNorm 
concepts for 
the 
specified 
term types 
getAllConceptsByTTY(
DF) 
STR: Injectable 
Solution 
TTY: DF 
RXCUI: 
316949 
 
STR: Inhalant 
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Powder 
TTY: DF 
RXCUI: 
317000 
 
STR: 
Ophthalmic 
Solution 
TTY: DF 
RXCUI: 7670 
 
 
2.4. Methods 
2.4.1. HHC Medication Record Data Converted to Coding Standards  
In Dierich’s study, medication record data was cleansed as follows: 
 Medication names were converted to generic names. 
 A patient’s “likely disease” was derived from the medication’s indication. 
(While the OASIS records contained ICD9 diagnostic values for a patient, 
the records were limited to one primary and five secondary diagnoses. In 
addition, medications were not linked to ICD9 codes, and could have been 
used for reasons for which there are no diagnostic codes.) 
 Medication dose forms, frequencies and special instructions were 
manually derived by splitting the medication text into appropriate 
concepts.   
To further prepare the data for this study, medication names were converted to 
RXCUI values with a TTY of IN or MIN. A SAS program was created that used 
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RXNORM APIs for this conversion (Figure 1).  Dierich’s medication dose forms were 
converted to RXCUI values with a TTY of DF using a RXNORM API. Dose forms that 
were not found by the API were converted to custom codes (Figure 2). In addition, a 
separate SAS program was created for future use to convert Medication RXCUI values 
with a TTY of SCD, SCDF, or SBD to Dose Form RXCUI values with a TTY of DF 
(Figure 3). 
“Likely diseases” were manually converted to ICD9 values for each patient based 
on the expertise of the authors – a doctorally prepared informatician (Olson), a geriatric 
nurse practitioner (Dierich), and a nurse researcher with expertise in geriatrics and home 
health care data (Westra), and validated against the Charlson comorbidity index.(M. E. 
Charlson, Pompei, Ales, & MacKenzie, 1987) A separate record was created for each 
patient consisting solely of “likely diseases” and corresponding ICD9 values.  
Lastly, medication frequencies and special directions were converted to custom 
codes from Dierich’s manually derived values from her previous study. No standard was 
found for these values in the literature. 
2.4.2. Polypharmacy Automated Algorithm 
Dierich defined polypharmacy as a continuous count of all regularly taken 
medications (prescribed or over the counter) via any route listed in the first episode of 
care.(Dierich, 2010) Polypharmacy was also used as a categorical variable for descriptive 
analysis; patients with less than 9 medications were assigned a “0” and patients with 9 or 
more medications were assigned a “1”. PRN medications (those used as needed), over-
the-counter medications and medications with limited dosing time such as antibiotics 
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were included in the count. The count excluded certain items documented in the patients’ 
medication records such as oxygen or saline used to dilute IV medications. Combination 
and variable dosed drugs were counted as one drug, rather than counting each active 
ingredient as a separate drug. 
An automated algorithm was created to count medication records containing RXCUI 
values, and also count each medication record whether or not an RXCUI value was 
assigned using the same logic and cleansed data as Dierich used in her study. 
2.4.3. Potentially Inappropriate Medications Automated Algorithm 
The 2003 version of the Beers’ criteria, a list of 48 drugs and 20 drug classes that 
the elderly should avoid, was used in Dierich’s study to create PIM scores.(Fick et al., 
2003) There is a newer version of the Beers criteria, but it was not available at the time of 
Dierich’s study, hence the same version was used in this study for comparison of the 
manual process and algorithm. In the Beers’ criteria, Fick et al. identified two categories 
of inappropriate drugs: PIM Table 1 includes those inappropriate for older adults no 
matter their diagnosis and PIM Table 2 includes medications that could be inappropriate 
depending on the diagnosis. The criteria also differentiated drugs by whether or not they 
posed risks of severe adverse outcomes (Appendix A). 
Fick et al did not assign scores to medications; hence, based on clinical judgment, 
Dierich operationalized the PIM criteria by assigning a score of 2.5 to each medication 
that was considered always inappropriate, and a score of 2 for each medication with a 
lower severity ranking. For medications with risks related to specific diseases, the 
assigned scores were 1.5 for medications with the highest risks and 1.0 for medications 
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with lower risks. A drug may have more than one score, and the highest score was kept 
for each drug. The medication scores were then summed to provide a total risk level score 
for each patient.
  
2.4.3.1. PIM Table 1 Automated Algorithm 
A SAS program was created to generate a crosswalk that maps drug names from 
PIM Table 1 to RXCUI values with TTY types of IN, MIN, BN, SCD, SCDF and SBD. 
The program used RXNORM APIs to generate the RXCUI values. It also assigned 
Dierich’s score to each medication record (Figure 4).  Another SAS program matched 
RXCUI crosswalk information and patient medication records to produce PIM Table 1 
scores (Figure 5). 
2.4.3.2. PIM Table 2 Automated Algorithm 
A SAS program was created to generate a crosswalk that maps medication names 
to RXCUI values, and medication classes to medication names to RXCUI values. The 
NLM Drug portal was used to map medication classes to medication names. A standard 
was not used for the drug class, and the medication class from PIM Table 2 was manually 
typed into the web portal which then displayed all medications for that drug class. A SAS 
program then converted the medication names to RXCUI values using RXNORM APIs.  
Clinical judgment was used to manually map diagnoses to ICD9 values. The ICD9 values 
were then assigned to each entry of the crosswalk along with Dierich’s score (Figure 6). 
Another SAS program combined medication records, patients’ likely diseases, and PIM 
Table 2 crosswalk data to produce patients’ PIM Table 2 scores (Figure 7). 
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2.4.4. Medication Regimen Complexity Automated Algorithm 
Dierich used a modified version of the Medication Regimen Complexity Index 
(MRCI) developed by George et al, because at the time it was “the only validated and 
reliable non-disease specific measure addressing medication complexity in the published 
literature.”(George et al., 2004) The index utilizes weighted scores in three subscales – by 
the complexity of their route (MRCI Table A), their dosing frequency (MRCI Table B), 
and their directions or preparation (MRCI Table C) – and then combines the subscale 
scores into a summary score (Appendix B). George et al. did not provide a cut point for 
highly complex regimens. Dierich used a continuous score in her structural equation 
modeling, and a cut point of 20 or above in her categorical data analysis as an indication 
of high medication regimen complexity.  
 
2.4.4.1. MRCI Table “A” Automated Algorithm 
A SAS program was created to generate a crosswalk that maps the dose forms 
from MRCI Table A to RXCUI values with a TTY type of DF using a RXNORM API. 
Dose forms that were not found with the API were converted to custom codes (Figure 8). 
Similar to its use in PIM scoring, a SAS program generated patients’ MRCI Table A 
scores through the input of medication records and MRCI Table A crosswalk data (Figure 
9).  
2.4.4.2. MRCI Table “B” and “C” Automated Algorithm 
   24 
 
 
SAS programs were created to generate a crosswalk that maps custom codes for 
dosing frequency and special directions to MRCI Table B and C.  Two other SAS 
programs were created to then generate patients’ MRCI Table B and C scores. The 
programs entered the medication records, and then MRCI Table B and Table C 
crosswalks, and produced the patients’ MRCI Table B (Figure 10) and C scores (Figure 
11). 
3. Results 
Results in this study include the percent of medications from Dierich’s study that 
were automatically mapped to RXCUI values for both dose forms and medication names, 
as well as the polypharmacy, PIM and MRCI patient scores that were produced through 
this conversion of drug names. 
3.1. Mapping Results 
Overall, 99% of drugs in the medication data set were converted to RXCUI 
values. Initially, without any manipulation of Dierich’s data, 82% of the drug names were 
converted to RXCUI values. The 82% consisted of exact generic drug names that were 
recognized by the API. After adjusting the data to redefine combination drugs with 
multiple ingredients into the naming formats that the NLM API expected, the match rate 
increased to 90%. (Dierich used “And” instead of “/” in the names for multi-ingredient 
drugs. So “aspirin and dipyridamole” was reformatted to “aspirin / dipyridamole”.) 
Another 9% of the drug records were then converted, either by using the brand names in 
Dierich’s data to find the active ingredient(s) RXCUI types of “IN” or “MIN,” or by 
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correcting misspellings in generic drug names. In the end, 1% of drug records could not 
be converted; they lacked specific generic or brand names. Rather, the medication terms 
represented broad medication categories such as “Laxative” or “Sports Cream”.  
Lastly, 80% of the dose forms in Dierich’s study were converted to RXCUI 
values. Custom codes were created for irrigant, g-tube, intravesicle, dressing, nebulizer 
and peg tube values. After adding custom codes, 100% mapping of dose forms was 
achieved. 
3.2. Polypharmacy Results 
Polypharmacy was calculated two ways: by counting medication records 
containing RXCUI values, and by counting each medication record whether or not an 
RXCUI value was assigned.  The count of all medication records for patients produced a 
100% match to Dierich’s data. The count of records with RXCUI values per patient 
produced a 99% match to Dierich’s data.  
3.3. PIM Table Results  
The match between the automation of patients’ PIM scores and Dierich’s manual 
PIM counts was 87%. PIM Table 1 consists of potentially inappropriate medications 
independent of patients’ diagnoses. PIM Table 2 consists of potentially inappropriate 
medications that were linked to diagnoses. Medications could have more than one score 
between PIM Table 1 and PIM Table 2; the highest score was assigned to the medication. 
In order to reach 87%, the manual calculations and logic in the automated design 
were adjusted (Table 3). The manual count, for example, included all long acting 
NSAIDs, such as diclofenac, whereas the automated count only included specific drugs in 
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PIM Table 1. These missing drugs from the manual count were added to the PIM Table 1 
crosswalk to be included in patients’ scores and to increase the match rate. The 
automation for PIM Table 2 found more drugs in diagnosis-specific drug classes than the 
manual scoring. More muscle relaxants such as quinine, for example, were found by the 
automated search of patients’ medication records. These drugs were removed from the 
PIM Table 2 crosswalk so they would not be included in the patients’ automated scores. 
The automation also caught mistakes made in the manual review, such as not applying 
medications consistently across all patients’ records. The correction of these errors 
resulted in modest changes to the manually derived PIM scores. 
 
Table 3:  Adjustments to Automated and Manual Logic 
Discrepancy with Manual Approach Resolution 
Automation only included dose amount 
for drugs which included amount 
guidelines such as ferrous sulfate >325 
mg/d  
Automation adjusted to 
include dose and frequency. 
Automation only considered specific 
drugs in PIM Table 1, even when a drug 
class was identified in combination with 
specific drugs. 
Automation adjusted to 
consider all drugs for 
muscle relaxants and 
antispasmodics, 
gastrointestinal 
antispasmodic drugs, 
anticholinergics and 
antihistamines. 
Automation did not identify tegaserod 
and scopolamine as anticholinergic. 
Tegaserod and scopolamine 
added to PIM Table 2 
crosswalk. 
Automation did not identify all 
benzodiazepines. 
Lorazepam, oxazepam, 
temazepam, alprazolam, and 
clonazepam added to PIM 
Table 1 & 2 crosswalks. 
Automation did not identify all stimulant 
laxatives. 
Senna and magnesium 
hydroxide added to PIM 
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Table 1 crosswalk. 
Automation did not exclude coxibs from 
NSAID drug Class. 
Rofecoxib and celecoxib 
removed from PIM Table 2 
crosswalk. 
Automated approach included quinine as 
a muscle relaxant. 
Quinine removed from PIM 
Table 2 crosswalk. 
 
The 13% that did not match included drugs that were obscured by the conversion 
of all drug names to their generic forms and to RXCUI values. For example, there is only 
one RXCUI value for the generic nifedipine. The manual calculations used the brand 
names and differentiated between long- and short-acting formulations of this medication. 
The automated design did not, because it utilized the single RXCUI value from the 
generic conversion. The drugs that did not match also included those with dose or form 
considerations such as Estrogen which were considered in the manual calculations but not 
the automated design. Future adjustments to the automated design could allow it to 
account for these considerations (Table 4). 
 
Table 4:  Future Adjustments  
Drug/Drug 
Class 
Issue Future Resolution 
Short acting 
nifedipine 
(Procardia and 
Adalat) 
Identifying 
short vs. 
long acting 
nifedipine 
The automated algorithm used the generic RXCUI 
value of 7531 (TTY = IN), because the medication data 
was stored with generic RXCUI values. 
 
Only RXCUI values related to short acting Nifedipine 
should be included in the PIM Table 1 crosswalk. The 
crosswalk may then be used with medication data 
stored with RXCUI formats which include the short 
acting specification. Examples below: 
491072 (TTY = SBDF): Nifedipine Extended Release 
Tablet [Adalat] 
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198034 (TTY = SCD): 24 HR Nifedipine 30 MG 
Extended Release Tablet 
672918 (TTY = SBD): 24 HR Nifedipine 90 MG 
Extended Release Tablet [Adalat] 
Muscle 
relaxants and 
antispasmodics: 
Do not consider 
the 
extended-
release 
Ditropan XL 
Identifying 
extended 
release 
Ditropan 
XL 
The automated algorithm used the generic RXCUI 
value of 32675 (TTY = IN) for oxybutynin.  
 
Exclusion criteria may be identified with RXCUI 
values stored in a format which includes the extended 
release specification. Examples below: 
863622 (TTY = SBD):  24 HR Oxybutynin chloride 10 
MG Extended Release Tablet [Ditropan] 863621 (TTY 
= SBDF):  Oxybutynin Extended Release Tablet 
[Ditropan] 
863619 (TTY= SCD): 24 HR Oxybutynin chloride 10 
MG Extended Release Tablet 
Estrogen (Oral) Identifying 
oral dose 
form 
The automated algorithm used the generic RXCUI 
value of 4099 (TTY = IN) for estrogen. 
 
Only RXCUI values for Oral Estrogen should be 
defined in the PIM Table 1 crosswalk. The crosswalk 
may then be used with medication data stored with 
RXCUI formats which include the oral dose form 
specification. Examples below: 
1441737 (TTY = SBDF): bazedoxifene / Estrogens, 
Conjugated (USP) Oral Tablet [Duavee] 
197662 (TTY = SCD): Estrogens, Conjugated (USP) 
1.25 MG Oral Tablet 
1441740(TTY = SBD): bazedoxifene 20 MG / 
Estrogens, Conjugated (USP) 0.45 MG Oral Tablet 
[Duavee] 
 
3.4. MRCI Table A Results 
 MRCI Table A consisted of complex dose forms and a corresponding 
weighting assigned to each entry of the table. The following results were produced for 
MRCI Table A: 
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 When the automation ran against a crosswalk that converted MRCI 
Table A dose forms to RXCUI dose form values, the match was 80% to Dierich’s 
manual calculations. 
 When the automation ran against a crosswalk that converted MRCI 
Table A dose forms to RXCUI dose form values, and included custom values for 
irrigant, g-tube, intravesicle, dressing, nebulizer and peg tube, the match was 99% 
to Dierich’s manual calculations. 
 
3.5. MRCI Table B & MRCI Table C Results 
MRCI Table B consisted of complex dose frequencies and a corresponding 
weighting assigned to each entry of the table. MRCI Table C consisted of complex 
special instructions and a corresponding weighting assigned to each entry of the table. 
The automation of patients’ MRCI Table B and MRCI Table C scores produced a 99% 
match. 
4. Discussion  
Automated analysis of clinical data is rapidly emerging as a way for health care 
providers to predict patient needs and risks for a variety of disorders and adverse 
events.(Deleger et al., 2013; Overby et al., 2013)  McDonald et al in 2012 created a 
successful approach to determining MCRI scores of patients in post-acute home care 
settings through an algorithm using medication data from their electronic health 
records.(McDonald et al., 2013) Medication data presents unique challenges in this 
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pursuit, though, because of the heterogeneous nature of prescription recordkeeping by 
different health care providers and the lack of standards for drug data coding and 
entry.(Richesson, 2014) RxNorm is viewed as an “ideal standard” for standardizing 
prescription data,(Richesson, Smith, Malloy, & Krischer, 2010) and making it available 
across health care systems for secondary analysis.(Rea et al., 2012) This study provides 
further validation of the utility of RxNorm and of automated algorithms for secondary 
analysis, and takes an important next step in applying this approach to the scoring of 
HRMRs, which Dierich showed have unique potential to assess medication-related risks 
for hospital readmissions. Automating HRMR calculations was a step that Dierich found 
necessary for further study in this area in order to “greatly improve the quality of 
research, the accuracy of findings, and the speed of release of findings.”(Dierich, 2010)  
4.1. Limitations  
The absence of coding standards from the data used in the original Dierich study 
created several limitations in terms of the ability to truly automate the process of 
assembling HRMR scores and analyzing patient readmission risks. If a medication record 
had a misspelling for a dose or medication name, an RXCUI value was not automatically 
found for that record, and manual editing was needed to clean up the database. 
For PIM Table 2, the NLM drug portal was used to find all the medication names 
associated with a medication class. This was not a truly automated process, and drug 
class coding standards were not used. Medication classes were typed into the portal to 
find associated medication names, and a SAS program was created to map the medication 
names to RXCUI values using RxNorm APIs. In addition, ICD9 values were manually 
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mapped to a patient’s likely disease. This study would have benefited from automation 
and tools to convert diagnosis text to ICD9 codes, just as this study utilized NLM APIs to 
convert medication names to RXCUI values. 
For MRCI Table A, the SAS program created to generate dose form RXCUI 
values, based on medication RXCUI values, was created for future use and was not 
validated with Dierich’s data. The data did not consist of medication records that were 
stored by Semantic Clinical Drug (SCD), Semantic Clinical Drug Dose Form 
Group (SCDG) or Semantic Clinical Drug Form (SCDF).For MRCI Tables B and C, 
informatics standards were not used, and custom codes were created for dose frequency 
and special instructions. 
The rapid expansion of electronic health records with common or relatable 
terminologies – increased by federal meaningful use financial incentives for hospitals and 
clinics(Heisey-Grove, Danehy, Consolazio, Lynch, & Mostashari, 2014) – would address 
some of the limitations experienced in this study. The standardization of prescription 
information is necessary so that physicians can review the safety of drug regimens with 
patients who transition out of hospitals or to new levels of care. A secondary benefit 
beyond this process of medication reconciliation is more consistency in the format of 
prescription information for data preparation and analysis. Federally funded projects such 
as SHARPn also are developing open source tools that extract clinical text from disparate 
EHRs and “normalize” it for secondary analysis.(Rea et al., 2012) An attempt at using the 
HRMR algorithm in this study with a dataset prepared under today’s EHR conditions and 
requirements would likely result in fewer setup problems. 
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5. Conclusion 
The tool developed in this study is a novel approach for assessing medication-
related readmission risks that can be replicated and applied across hospital and health 
care recordkeeping systems. The APIs available through the NLM website, and the 
crosswalks generated, allow the algorithm to be adapted and adjusted in other systems for 
future clinical analysis and research. An important next step is to adjust criteria in the 
automated algorithm to determine optimal cut-points that separate patients at higher risk 
of hospitalization from patients who have lower risk based on their high risk medication 
regime scores. The scores of 2.5, 2, 1.5 and 1 that Dierich used for PIM calculations were 
arbitrary based on clinical judgment. Future users could determine that greater scoring 
weight should be given to certain medications, such as those presenting the greatest risks 
of severe adverse outcomes. Using the algorithm to identify the most sensitive scores and 
cut-points will hasten the use of HRMR as a meaningful source of patient information in 
clinical, hospital and home health care systems. 
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Background: Unnecessary hospital readmissions are costly for the U.S. health 
care system. An automated algorithm was developed to target this problem and proven to 
predict elderly patients at greater risk of rehospitalization based on their medication 
regimens. 
Objective: Improve the algorithm for predicting elderly patients’ risks for 
readmission by optimizing the sensitivity of its medication criteria. 
Methods: Outcome and Assessment Information Set (OASIS) and medication 
data were reused from a study that defined and tested an algorithm for assessing 
rehospitalization risks of 911 patients from 15 Medicare-certified home health care 
agencies. Odds Ratio analyses, literature reviews and clinical judgments were used to 
adjust the scoring of patients’ High Risk Medication Regimens (HRMRs). Receiver 
Operating Characteristic (ROC) analysis evaluated whether these adjustments improved 
the predictive strength of the algorithm’s components.   
Results: HRMR scores are composed of polypharmacy (number of drugs), 
potentially inappropriate medications (PIM) (drugs risky to the elderly), and Medication 
Regimen Complexity Index (MRCI) (complex dose forms, dose frequency, instructions 
or administration). Strongest ROC results for the HRMR components were Areas Under 
the Curve (AUC) of .68 for polypharmacy when excluding supplements; and .60 for PIM 
and .69 for MRCI using the original HRMR criteria. The “cut point” identifying MRCI 
scores as indicative of medication-related readmission risk was increased from 20 to 33. 
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Conclusion: The automated algorithm can predict elderly patients at risk of 
hospital readmissions and its underlying criteria is improved by a modification to its 
polypharmacy definition and MRCI cut point.  
 
Keywords: Patient readmission, Polypharmacy, Medication Adherence, Home 
Care Agencies, ROC Curve. 
 
1. Introduction 
Medications can both enhance health and cause adverse events, particularly for 
older adults, whose prescription regimens increase with age and chronic health 
problems.(Hung, Ross, Boockvar, & Siu, 2011) Nine in ten older adults take at least one 
prescription medication and most take more than five.(Qato et al., 2008) The combination 
of health conditions and chemical ingredients in medications can increase older adults’ 
risk of adverse events and need for emergency medical care.(Centers for Disease Control 
and Prevention (CDC), 2012) Avoidable readmissions to hospitals have been linked to 
problems with medication usage,(Freund et al., 2013; Kripalani, Theobald, Anctil, & 
Vasilevskis, 2013) but efforts to identify and predict which patients suffer this adverse 
event have been mixed. Studies have explored a connection between readmissions and 
the numbers of drugs patients take (polypharmacy)(Morandi et al., 2013; Sganga et al., 
2014), their use of potentially inappropriate medications (PIM)(Price et al., 2014a; Price, 
Holman, Sanfilippo, & Emery, 2014b; Sehgal et al., 2013), and the complexities of the 
doses or forms of their medications (Medication Complexity Index (MRCI))(Willson et 
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al., 2014; Wimmer et al., 2014). Mary Dierich theorized that limitations of these 
individual medication measurements might be addressed by constructing them into a 
combined measurement, the High Risk Medication Regimen (HRMR). In an initial study 
of 911 elderly home health care patients, HRMRs accounted for 10 percent of the 
variance in hospital readmissions, making them more predictive than comorbidity. 
(Dierich, 2010)  
The potential utility of HRMR as a clinical decision support tool to prevent 
avoidable readmissions – which can now result in federal Medicare penalties if hospitals 
report too many of them(Abelson, 2013) – was tempered by the labor-intensive process in 
the original study for calculating the scores. Further research subsequently developed an 
automated tool that maps medication data to RxNorm coding standards and created an 
algorithm with the coded medication data to calculate patients’ HRMR scores.(Olson et 
al., 2014) The standardized format of the coded data addressed some of the practical 
challenges of using HRMR for clinical decision support, and also made the algorithm 
potentially useable across different electronic health record (EHR) systems and health 
care organizations. Automating the calculation also allowed for more rapid testing of the 
criteria underlying this new combined measurement and the “cut points,” which were 
manually selected based on the researchers’ clinical expertise and literature review, that 
distinguish patients at high and low risk of rehospitalization. This study sought to take 
advantage of that advancement by testing adjustments to the HRMR criteria and to the 
cut points to determine the optimal calculation for predicting medication-related 
rehospitalizations of elderly home health care patients.  
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1.1 Objectives 
The objective of this study was to improve the automated algorithm for predicting 
hospital readmissions by optimizing the underlying criteria within the algorithm and 
determining the optimal cut points for HRMR scores. Optimizing the algorithm’s criteria 
is a key next step in advancing the HRMR concept toward clinical utility. 
  
2. Methods 
2.1. Data Set 
This study used Outcome and Assessment Information Set (OASIS) and 
medication records for 911 adults from 15 Medicare-certified home health care agencies 
that were used in previous studies.(Dierich, 2010; Olson et al., 2014) The medication 
records included both prescription and over-the-counter medications taken by patients in 
their homes and recorded by home care clinicians in their EHRs. Medication data 
included the medication names, doses, dose forms, frequencies and special instructions. 
OASIS data for the patients, all of whom were at least 65 and were admitted from the 
hospital to the home health care agencies in 2004, included demographic, environmental, 
support system, health and functional status, and health service utilization 
information.(Centers for Medicare and Medicaid Services (CMS), 2012a) 
2.2. Data Analysis 
Dierich operationalized the medication data by first calculating polypharmacy, 
PIM and MRCI scores based on patients’ drug regimens, and then using summative 
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factor analysis to construct those weighted scores into a combined HRMR 
measurement.(Dierich, 2010) The original HRMR research defined polypharmacy as nine 
or more medications. Scores of “0” were assigned for patients with fewer than 9 
medications, and “1” for patients with 9 or more medications.  
Scores for PIM were based on the 2003 version of the Beers’ criteria, a list of 48 
drugs and 20 drug classes that the elderly should avoid. In defining the Beers’ criteria, 
Fick et al. (Fick et al., 2003) differentiated drugs by whether or not they posed risks of 
severe adverse outcomes, and whether they were inappropriate for older adults regardless 
of diagnosis (PIM schedule 1) or inappropriate depending on the diagnosis (PIM schedule 
2). The initial HRMR research assigned weighted scores of 2.5 to medications that were 
always inappropriate and carried the greatest risks, 2 for medications with lower risks of 
severe outcomes, 1.5 for medications with the highest risks for certain diagnoses, and 1.0 
for medications with lower risks for certain diagnoses. (Drugs that met multiple criteria 
received the higher score.) The medication scores were then summed to provide a total 
PIM risk level score for each patient.  
The original HRMR research used a modified version of the Medication Regimen 
Complexity Index developed by George et al. (George et al., 2004) that weighted drugs 
by three subscales – by the complexity of their route (MRCI Schedule A), their dosing 
frequency (MRCI Schedule B), and the complexity of their directions or preparation 
(MRCI Schedule C) – and then combined the subscale scores into a summary score 
(Figure IV). A summary score cut point of 20 or above was set in the original HRMR 
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research as an indication of high medication regimen complexity, though it was an 
“arbitrary” distinction due to the lack of prior research.(Dierich, 2010) 
This method of assigning weighted scores to predictive variables is similar to 
what was used in the development of the Charlson index of comorbidity for predicting 
mortality risks,(M. Charlson, Szatrowski, Peterson, & Gold, 1994) and another recent 
analysis that identified factors for predicting early and preventable rehospitalizations after 
kidney transplants.(Harhay et al., 2013) 
2.2.1. ROC Analysis. Receiver Operating Characteristic (ROC) curves were used 
in this study to evaluate optimization of the algorithm and determine optimal cut points 
for the HRMR components (Polypharmacy, PIM, and MRCI) associated with 
rehospitalization. The ability to identify cut points is considered an advantage of ROC 
analysis.(Hajian-Tilaki, 2013) The area under the ROC curves (AUC) can be interpreted 
in this study as the probability of correctly predicting rehospitalization, based on 
sensitivity and specificity. The closer the AUC is to 1, the better the measure. An AUC 
resultabove .7 is considered meaningful by one generic value scale(Tape, ), but studies 
have characterized results between .6 and .7 as “moderate” or “good.”(Akyuz, Alpsoy, 
Akkoyun, Degirmenci, & Guler, 2014; Cheung, 2014; Heng et al., 2014; Hiersch et al., 
2014; Malik, Banning, & Gershlick, 2014) ROC curves are frequently used to assess the 
value of predictive measures, and have been used to optimize the analysis of patients who 
had poor outcomes after hospitalization for inflammatory pelvic disease,(Terao et al., 
2013) and to create a prognostic index of patient mortality after intensive care.(Cardoso 
& Chiavone, 2013)  
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In using the ROC results to select cut points for the HRMR components, the 
authors reviewed common mathematical approaches such as the Youden index(Greiner, 
Pfeiffer, & Smith, 2000) but opted on a customized approach in an attempt to account for 
the prevalence of hospital readmissions and also the expense of testing overall and of 
false positive results. The authors had to fundamentally decide whether to err in the 
selection of cut points on the side of sensitivity (the ability of a test to correctly identify 
people with a medical condition) or on specificity (the ability to rule out people who 
don’t have a particular disease or medical problem). The dilemma has been described, 
respectively, as whether a test should “rule in” patients for further consideration of a 
medical issue, or “rule out” their risks.(Florkowski, 2008) A “rule in” approach was 
adopted here, with the presumption that clinicians would use an HRMR screening to 
evaluate patients at risk and then conduct further clinical assessments of their needs. This 
favored cut points weighing more heavily on sensitivity, at the expense of specificity and 
a higher rate of false positive results. An initial target of .75 for sensitivity and .50 for 
specificity was chosen for the revision of cut points for the HRMR components. 
2.2.2. Odds Ratio. Odds ratio (OR) computations were used to test the strength of 
the relationship between HRMR and rehospitalization risks and compare the original 
scoring criteria  with newly derived HRMR scoring criteria using ORs. Odds ratios 
indicated whether the relative odds of the occurrence of rehospitalization were different 
for each of the independent variables that make up PIM (disease and medication class, 
and medications) and MRCI (dose form, instructions, and frequency). The intent was for 
the relative odds of the independent variables to be applied to the HRMR algorithm to see 
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if they generated better AUC curve results and more optimal cut points for predicting 
rehospitalization rather than the original scoring criteria.   
2.3. Data Transformations  
Adjustments to the original HRMR scoring criteria were made based on clinical 
observations and expertise of the authors – a doctorally prepared informatician, a 
geriatric nurse practitioner, a nurse researcher with expertise in geriatrics and home 
health care data, and a physician who is also a clinical pharmacist. These transformations 
were attempted to optimize the criteria of the algorithm and the HRMR cut points, and 
the methodologies behind them are described below:  
 
2.3.1. Polypharmacy 
PRN medications (taken as needed), over-the-counter medications, and 
medications with limited dosing time such as antibiotics were included in the original 
HRMR research, while other more benign items such as oxygen or saline to dilute IV 
medications were excluded. Combination and variable dosed drugs were counted as one 
drug. 
 Based on clinical judgment and polypharmacy criteria in other recent 
publications,(Abdulraheem, 2013; Beloosesky, Nenaydenko, Gross Nevo, Adunsky, & 
Weiss, 2013) this study modified the polypharmacy scoring for HRMR calculations by 
excluding acetaminophen, vitamins, supplements, and PRN medications from the 
medication count. ROC curves were used to compare the predictive strength of the 
original HRMR scoring with these modified scores. 
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2.3.2. Potentially Inappropriate Medications 
This analysis modified the PIM scoring criteria, based on clinical observation and 
a review of recent publications regarding adverse drug events related to certain drug 
classes.Two additional higher-risk categories were created for selected drugs in PIM 
schedule 1 (those always inappropriate regardless of diagnosis) and assigning them 
greater scoring weights (Table 1).
 
 Highest (assigned weight of 10) included antispasmodics and long-acting 
benzodiazepines due to adverse central nervous system effects and dementia and 
increased sensitivity with age. Antispasmodics also have uncertain effectiveness 
and are highly anticholinergic while the benzodiazepines present an elevated risk 
of falls.(American Geriatrics Society 2012 Beers Criteria Update Expert Panel, 
2012) 
 Medium (assigned weight of 5) included digoxin due to potential toxic effects and 
nitrofurantoin and thioridazine due to known risks and the availability of safer 
alternatives for the treatments, respectively of infections and psychosis. 
 Remaining PIM schedule 1 drugs retained their assigned weights (2.5 and 2) from 
the original analysis as did schedule 2 drugs (1.5 and 1). 
 
Odds ratio analysis also was applied to PIM schedules 1 and 2 using the 
independent variables of high-risk medications and medications with disease-specific 
risks in the elderly. The intent of this analysis was to apply the relative odds of 
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rehospitalization for each of the independent variables to the algorithm to determine if 
they were stronger than the weighted scores in the original HRMR research.  
ROC analysis then was used to see if either of the modified PIM scoring criteria – 
one derived from clinical judgment and literature review, the other from the OR analysis 
– were better at identifying patients needing rehospitalization than the original scoring 
criteria. 
2.3.3 Medication Regimen Complexity Index (MRCI).  
ROC analysis then compared the predictive strength of MRCI in identifying 
patients who will be rehospitalized against modified criteria, including MRCI schedules 
A, B and C individually; and schedules A and C together only. The latter was done to 
address a theory that schedule B (dosing frequency) might be redundant with 
polypharmacy. 
In addition, odds ratio analyses were applied to schedules A, B, and C using 
independent variables of dose form, frequency and special dosing instructions to 
understand the relative odds of rehospitalization. The intent of this analysis was to apply 
the relative odds of rehospitalization for each of the independent variables to the 
algorithm instead of George’s original weighted scores. ROC analysis was again used to 
test the independent variables and whether they optimized the algorithm.  
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3. Results 
Table 2 summarizes results of the ROC analyses. 
3.1 Polypharmacy 
Removing vitamins and supplements from the medication counts improved the 
AUC slightly (.66 vs. .68) (Figure I). Removing PRN medications did not improve the 
AUC (.66) and removing acetaminophen caused the AUC to decrease (.64). Using the 
criteria that produced an AUC of .68 (the analysis in which vitamins and supplements 
were removed), the optimal cut point remained 9. This was based on a true positive rate 
of .77 and a false positive rate of .53. 
3.2 Potentially Inappropriate medications (PIM) 
The original automated PIM algorithm produced an AUC curve of .6 (Figure II). 
When weights based on clinical observation were applied to the algorithm, there was no 
improvement to the original HRMR weights, producing a curve of .59. 
When the odds ratio analysis was applied to each independent variable (risky 
medications) in PIM schedule 1 (Table III) and each independent variable (risky 
medications considering diagnosis) in PIM schedule 2 (Table IV), the resulting models 
produced confidence intervals which contained one for each independent variable, 
meaning the model was not valid. 
Therefore, there was no support of an independent PIM effect on the odds of the 
outcome (rehospitalization)). As a result, adjusted weights based on odds ratio analysis 
were not applied to the algorithm to improve the AUC curve of .60. 
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3.3. Medication Complexity Index (MRCI) 
MRCI schedules A, B, and C, when calculated separately, showed similar results 
(.68, .68, .69) as when all MRCI schedules were calculated together (.69). (Figure III) A 
cut point of 33, higher than the original 20, produced a true positive rate of .76 and a false 
positive rate of .49 – meeting the goal in the study for establishing HRMR as a rule-in 
test for readmission risks. When the odds ratio analysis was run on each component of 
schedule A, B, and C, the only schedule which produced a statistically valid model was 
C. Schedules A and B produced models in which each of the independent variables had 
confidence intervals which contained 1. Therefore, dose form and frequency were not 
supported to have an independent effect on the relative odds of the outcome 
(rehospitalization). Schedule C’s model produced valid confidence intervals for 7 of 10 
independent variables. (Table V) The other three variables were removed from the model 
as their confidence intervals also were weak. 
Rounding to the nearest whole number, each point estimate is identical to 
George’s original weights for the MRCI variables. (Figure IV) The only exception is the 
variable for “multiple units at one time”; the odds ratio analysis gave that a greater 
rounded weight (2 points) than George’s original analysis (1 point). After rerunning the 
ROC curve for MRCI with these modified weights, the AUC remained unchanged at .69. 
Using the actual results from the Odds Ratio analysis, instead of rounding to match 
George’s methodology, produced a slightly stronger .7 AUC  result for schedule C’s 
influence on rehospitalization risks. 
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4. Discussion 
This study determined optimal criteria for an algorithm using HRMR scores to 
predict elderly patients at risk for rehospitalization, and contributed to an acceleration of 
research in the area of medications and hospital readmissions. Two other studies both 
attributed hospital readmissions in the elderly to polypharmacy(Morandi et al., 2013; 
Sganga et al., 2014) – though they used different criteria – while a third concluded that 
both polypharmacy and PIM are “under recognized causes of readmissions to the 
hospital.”(Sehgal et al., 2013) But while the components of HRMR draw increasing 
research interest, there has been little follow-up to the initial discovery that HRMR is 
uniquely associated with hospital readmission risks.(Dierich, 2010) This could owe to the 
fact that HRMR and the MRCI component itself are relatively new to medical research. 
PubMed shows only 33 studies referring to MRCI, with one associating it with hospital 
readmissions in the elderly.(Willson et al., 2014)  
The ROC analysis supported that polypharmacy is a strong component of the 
HRMR model, and was slightly more predictive of rehospitalizations when vitamins and 
supplements were removed from patients’ drug counts. This exclusion mimics 
approaches used in other studies(Beloosesky et al., 2013) and argues in favor of 
removing vitamins and supplements from future studies linking polypharmacy to 
rehospitalization and related outcomes. Supplements are not risk-free for seniors,(Mursu, 
Robien, Harnack, Park, & Jacobs, 2011) but they are widely taken for general 
health.(Kaufman, Kelly, Rosenberg, Anderson, & Mitchell, 2002) Removing them might 
have sharpened the algorithm’s ability to identify rehospitalizations by focusing on sicker 
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patients whose high polypharmacy counts consisted of more prescription medications. 
The results were weakened by the removal of acetaminophen, which also is taken broadly 
by seniors for general pain relief,(Kaufman et al., 2002) but has documented risks such as 
drug-induced liver injury(Leise, Poterucha, & Talwalkar, 2014; Yuan & Kaplowitz, 
2013) that could make it more relevant to this HRMR analysis. 
An ancillary benefit of the study is its contribution to the global definition of 
polypharmacy. The original HRMR cut point for polypharmacy was 9 or more drugs, one 
that is commonly but not exclusively used in research, and further analysis showed a 
polypharmacy cut point of 9 optimized the algorithm and the prediction of patients at risk 
for rehospitalization. This could serve as a guide for future research. 
Results for PIM schedules showed they were weaker components of the HRMR 
calculation in estimating patient rehospitalization risks. PIM in other studies has had a 
dependent relationship with polypharmacy, in that the more drugs elderly patients have, 
the more likely they are to have inappropriate prescriptions in their regimens.(Vieira de 
Lima, Garbin, Garbin, Sumida, & Saliba, 2013; Weng et al., 2013). Attempts to 
strengthen PIM by revising cut points were unsuccessful in this study as the AUC curves 
produced were only slightly better than chance. While at least one study has associated 
PIM with readmissions,(Price et al., 2014a) our findings agree with other studies that 
have found PIM alone to be predictive of other problems, such as inpatient falls, but not 
rehospitalization.(Borenstein et al., 2013) Despite its weak relationship to 
rehospitalizations on its own, PIM nonetheless appears an important component of the 
HRMR construct. Dierich’s original study found HRMR to be “more than the sum of its 
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parts” and that PIM played a role in its predictive strength.The original MRCI scoring 
weights from George’s research also proved optimal, though adjustments based on an 
odds ratio analysis did modestly improve the predictive strength of schedule C (drugs 
with special instructions). ROC results for both HRMR components approached .7, which 
is a statistical threshold. This analysis also adjusted the cut point that distinguishes 
patients at greater risk of rehospitalization to 33 for MRCI (the original cut point in the 
HRMR calculation was 20). This is one of the first attempts in research literature at 
establishing such a cut point for the use of MRCI in predictive tests.  
 This study suggests a need for more targeted research on HRMR scores and 
whether they can predict adverse outcomes among the elderly in ways that other 
measures of medications and medication regimens cannot.  
4.1 Limitations 
 Odds ratio and ROC analysis are common validation tools in medical research for 
the development of predictive tools and indexes, but they are ultimately dependent upon 
the criteria and information selected for analysis. Medical researchers have not arrived on 
a common definition for polypharmacy, with cut points often ranging from 2 to 9,(Hajjar, 
Cafiero, & Hanlon, 2007) and have varied in their inclusion of over-the-counter 
medications. This study used a PubMed literature search and clinical judgments of its 
authors to decide which medications and medication classes to exclude from the weighted 
scoring of both polypharmacy and PIM in the calculations of HRMR scores. Due to the 
broad number of drug inclusion and exclusion combinations, it is possible that relevant 
adjustments to the weighted scores were not tested and identified in this research. For 
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continuity with Dierich’s original HRMR research, it was necessary to use the original 
2003 Beers criteria, though a significant update was produced in 2012.(American 
Geriatrics Society 2012 Beers Criteria Update Expert Panel, 2012) Although the two lists 
have “substantial agreement,”(Baldoni et al., 2013) nineteen classes of drugs were 
removed in the latest update – in some cases because the drugs were removed from the 
U.S. market – while other common medications such as atypical antipsychotics were 
added. Further research using the updated criteria and its inclusion of antipsychotics and 
other medications could alter how PIM counts contribute to research involving HRMRs 
and to the strength of HRMRs in predicting readmission risks. 
5. Conclusion 
HRMR calculations are optimized by adjusting the underlying criteria of 
polypharmacy to exclude supplements and vitamins from the count of medications, and 
by increasing the MRCI cut point that distinguishes patients by their medication-related 
risks for hospital readmissions. While modest, the changes strengthen the case for an 
HRMR algorithm that clinicians can use to assess elderly patients’ risks for avoidable 
readmissions.Next steps include testing the automated HRMR algorithm with the 
prescription and OASIS data of different populations to see if can be optimized further. 
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Tables 
Table 1: Potentially Inappropriate Medications: Independent of Diagnoses or 
Conditions, from Fick et al. (2003, p. 2719), used with permission. 
New Scoring:   **Highest (10), *Medium (5) 
Note: Remaining PIM Table 1 drugs retained their assigned weights (2.5 and 2). 
Drug/Drug Combinations with the Active Ingredient Low 
Risk 
High 
Risk 
Propoxyphene (Darvon) X  
Indomethacin (Indocin)  X 
Pentazocine (Talwin)  X 
**Muscle relaxants and antispasmodics: methocarbamol (Robaxin), 
carisoprodol (Soma), chlorzoxazone (Paraflex), metaxalone 
(Skelaxin), cyclobenzaprine (Flexeril), and oxybutynin (Ditropan). 
Do not consider the extended-release Ditropan XL. 
 X 
**Flurazepam (Dalmane)  X 
**Amitriptyline (Elavil), chlordiazepoxide-amitriptyline 
(Limbitrol), and perphenazine-amitriptyline (Triavil) 
 X 
Doxepin (Sinequan)  X 
Meprobamate (Miltown and Equanil)  X 
Doses of short-acting benzodiazepines: doses greater than 
lorazepam (Ativan), 3 mg; oxazepam (Serax), 60 mg; alprazolam 
(Xanax), 2 mg; temazepam (Restoril), 15 mg; and triazolam 
(Halcion), 0.25 mg 
 X 
**Long-acting benzodiazepines: chlordiazepoxide (Librium), 
chlordiazepoxide-amitriptyline (Limbitrol), clidinium-
chlordiazepoxide (Librax), diazepam (Valium), quazepam (Doral), 
halazepam (Paxipam), and chlorazepate (Tranxene) 
 X 
Disopyramide (Norpace and Norpace CR)  X 
*Digoxin (Lanoxin) (should not exceed _0.125 mg/d except when 
treating atrial arrhythmias) 
X  
Short-acting dipyridamole (Persantine). Do not consider the long-
acting dipyridamole (which has better properties than the short-
acting in older adults) except with patients with artificial heart 
valves 
X  
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Methyldopa (Aldomet) and methyldopa-hydrochlorothiazide 
(Aldoril) 
 X 
Reserpine at doses > 0.25 mg X  
Chlorpropamide (Diabinese)  X 
*Gastrointestinal antispasmodic drugs: dicyclomine (Bentyl), 
hyoscyamine (Levsin and Levsinex), propantheline (Pro-Banthine), 
belladonna alkaloids (Donnatal and others), and clidinium-
chlordiazepoxide (Librax) 
 X 
**Anticholinergics and antihistamines: chlorpheniramine (Chlor-
Trimeton), diphenhydramine (Benadryl), hydroxyzine (Vistaril and 
Atarax), cyproheptadine (Periactin), promethazine (Phenergan), 
tripelennamine, dexchlorpheniramine (Polaramine) 
 X 
**Diphenhydramine (Benadryl)  X 
Ergot mesyloids (Hydergine) and cyclandelate (Cyclospasmol) X  
Ferrous sulfate >325 mg/d X  
**All barbiturates (except phenobarbital) except when used to 
control seizures 
 X 
**Meperidine (Demerol)  X 
Ticlopidine (Ticlid)  X 
**Ketorolac (Toradol)  X 
**Amphetamines and anorexic agents  X 
Long-term use of full-dosage, longer half-life, non–COX-selective 
NSAIDs: naproxen (Naprosyn, Avaprox, and Aleve), oxaprozin 
(Daypro), and piroxicam (Feldene) 
 X 
Daily fluoxetine (Prozac)  X 
Long-term use of stimulant laxatives: bisacodyl (Dulcolax), cascara 
sagrada, and Neoloid except in the presence of opiate analgesic use 
 X 
*Amiodarone (Cordarone)  X 
Orphenadrine (Norflex)  X 
Guanethidine (Ismelin)  X 
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Guanadrel (Hylorel)  X 
Cyclandelate (Cyclospasmol) X  
Isoxsurpine (Vasodilan) X  
*Nitrofurantoin (Macrodantin)  X 
*Doxazosin (Cardura) X  
Methyltestosterone (Android, Virilon, and Testrad)  X 
*Thioridazine (Mellaril)  X 
Mesoridazine (Serentil)  X 
Short acting nifedipine (Procardia and Adalat)  X 
Clonidine (Catapres) X  
Mineral oil  X 
Cimetidine (Tagamet) X  
Ethacrynic acid (Edecrin) X  
Desiccated thyroid  X 
Amphetamines (excluding methylphenidate hydrochloride and 
anorexics) 
 X 
Estrogens only (oral) X  
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Table 2: Summary Results – ROC Analysis 
Polypharmacy 
 
AUC 
Original Dierich - Manual & Automated 0.66 
PRN Medications Only 0.65 
All Medications except PRN 0.64 
All Medications except  acetaminophen 0.66 
All Medications except vitamins and supplements 0.68 
PIM 
 
AUC 
Original PIM Manual 0.6 
Original PIM Automated 0.59 
Clinical Expertise - Modified 4 Scale 0.59 
MRCI 
 
AUC 
Original Dierich 0.69 
Table A&C Only 0.69 
Table A 0.68 
Table B 0.68 
Table C 0.69 
Odds Ratio  0.69 
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Table 3: PIM Table 1- Sample Odds Ratio Analysis Results  
Odds Ratio Estimates 
 
Effect 
Point 
Estimate 
95% Wald 
Confidence Limits 
Alprazolam 0.90 0.29 2.75 
amitriptyline 0.51 0.18 1.47 
Bisacodyl 1.42 0.81 2.49 
 
 
Table 4: PIM Table 2- Sample Odds Ratio Analysis Results  
Odds Ratio Estimates 
 
Effect 
Point 
Estimate 
95% Wald 
Confidence Limits 
Chronic Constipation and CCB 0.91 0.68 1.22 
Clot Disorder and NSAID 0.78 0.48 1.25 
Parkinson’s and Antipsychotics 2.93 0.59 14.53 
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Table 5: MRCI Odds ratio analysis for Table C 
Odds Ratio Estimates 
 
 
Effect Point Estimate 
95% Wald 
 Confidence Limits 
 Variable dose 1.34 1.09 1.65 
 Take/use at specified time/s 1.33 1.11 1.58 
 Tapering/increasing dose 2.52 2.27 2.79 
 Alternating dose 1.69 1.31 2.18 
 Take/use as directed 2.39 2.19 2.60 
 Relation to food 1.51 1.35 1.70 
 Multiple units at one time 1.85 1.56 2.20 
 Dissolve tablet/powder** 1.29 0.83 1.99  
Break or crush tablet** 1.23 0.84 1.81  
Take with specific fluid** 
 
1.75 0.32 9.54 
 **Variables removed from model due to weak confidence intervals. 
 
 
 
 
 
 
 
   63 
 
 
Figures 
Figure 1: ROC Curves for Polypharmacy  
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Figure 2:  ROC Curve for PIM   
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Figure 3: ROC Curve for MRCI  
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 Introduction: High Risk Medication Regimen (HRMR) scores are weakly 
predictive of hospital readmissions for elderly home health care patients. One possibility 
is that HRMR scores are more predictive for demographic subgroups of elderly patients. 
HRMR is composed of three elements related to drug risks: polypharmacy (number of 
medications); Potentially Inappropriate Medications (PIM) known to be harmful to the 
elderly; and the Medication Regimen Complexity Index (MRCI) that weighs drugs by the 
complexity of their dosing and instructions. This study used Outcome and Assessment 
Information Set (OASIS) variables to identify subgroups of patients for whom the HRMR 
measures appeared more predictive for hospital readmissions. 
 Methods: OASIS and medication data were reused from a study of 911 patients 
from 15 Medicare-certified home health care agencies that established the relationship 
between HRMR and hospital readmissions. Hierarchical agglomerative clustering using 
the Jaccard distance measure and average-link method identified patient subgroups based 
on the OASIS data. Receiver operating curve (ROC) analyses evaluated the predictive 
strength of the HRMR variables for each subgroup. Additional False Discovery Rate 
(FDR) analyses assessed whether the clustered relationships were chance. 
 Results: Clustering of OASIS data for 911 patients identified six subgroups 
(patients with good functional status, females with moderate to severe pain, patients with 
poor prognosis needing functional status assistance, patients with poor functional status, 
males with adult children as caregiver, adults living alone with spouses as primary 
caregiver.) ROC results relating these subgroups to HRMR risks were strongest for males 
with adult children as caregivers (AUC: polypharmacy, .73; PIM, .64; MRCI, .77). The 
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findings for this subgroup also met the FDR analysis threshold (<=.20).  
 Conclusions: A risk of medication-related readmissions in elderly men with adult 
children as caregivers is consistent with research showing problems in medication 
adherence when seniors are supported by informal caregivers. The results from clustering 
analysis present a hypothesis for research on HRMR and on the relationship between 
adult caregivers and their fathers. 
 
 Keywords: Patient Readmission, Caregiver, Cluster Analysis, home healthcare, 
High Risk Medication Regimen 
 
1. Introduction 
 Reducing hospital readmissions has become a focus for U.S. hospitals and health 
care systems following research showing that a substantial number of them are 
unplanned(Jencks et al., 2009) and preventable(Kripalani et al., 2013), and that they 
result in as much as $25 billion each year in “wasteful” health care spending.(National 
Quality Forum, 2010a) Beyond the costs, preventing readmissions is a patient safety issue 
because hospital care in general exposes patients to risks, including adverse drug events, 
infections, delirium and cognitive decline.(Donze, Lipsitz, Bates, & Schnipper, 2013) 
While transitional and home health care strategies have been developed to prevent 
patients from needing readmissions,(Berry et al., 2011; Hunter, Nelson, & Birmingham, 
2013; Markley, Sabharwal, Wang, Bigbee, & Whitmire, 2012) they are costly 
interventions if provided universally to patients upon their discharges.(Donze et al., 2013) 
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Identifying patients at greatest risk for hospital readmission has consequently become a 
priority. Medication usage by elderly homecare patients has emerged as an important 
indicator of hospital readmission risk (Morrissey et al., 2003; National Quality Forum, 
2010a) with one study finding a composite measure of High Risk Medication Regimens 
(HRMR) more strongly associated with hospital readmissions than the presence of 
comorbid conditions.(Dierich, 2010) This was a substantial finding given the number of 
studies linking comorbidity to avoidable readmissions.(Donze et al., 2013; Librero, Peiro, 
& Ordinana, 1999; Zekry et al., 2012) Further analysis found these HRMR calculations 
could be automated and potentially integrated into clinical information systems to 
identify at-risk patients for hospital readmission and provide them with supportive and 
preventive services.(Olson et al., 2014) Opportunities to further identify the patients at 
greatest risk of HRMR-related hospital readmissions are possible due to home healthcare 
providers implementing electronic health record (EHR) systems and the development of 
data mining tools that can be used to find patterns within the EHR data. Data mining 
techniques have already been used to identify home healthcare patients that are more 
adaptive to assistive technology(S. Zhang et al., 2014) and those able to show greater 
improvement from incontinence(Westra et al., 2011). The purpose of this study was to 
apply data mining techniques to determine if certain clusters of patients were more likely 
to have high-risk drug regimens and consequently be at greater risk of hospital 
readmissions. The results could prove instructive to the hospitals and health systems 
trying to reduce their readmission rates – both to improve patient care and avoid new 
Medicare penalties for having more readmissions than expected of patients treated for 
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pneumonia, heart failure or acute myocardial infarction.(Abelson, 2013) 
1.1. Objective 
 This study sought to (1) optimize the utility of the automated HRMR algorithm by 
using data mining to determine if specific patient populations were more at risk for 
medication-related hospital readmissions, and (2) use the data from the federal Outcome 
and Assessment Information Set (OASIS) to characterize and group patients for the 
assessment of risk for medication-related hospital readmissions.  
2. Materials and Methods 
 This study used EHR data from a previous study consisting of OASIS home 
healthcare records and medication records for 911 adults from 15 Medicare-certified 
home health care agencies.(Dierich, 2010; Olson et al., 2014) OASIS data for the 
patients, all of whom were 65 or older and admitted from hospitals to home healthcare, 
were from 2004 and included demographic, environmental, support system, health and 
functional status, and health service utilization information.(Centers for Medicare and 
Medicaid Services (CMS), 2012a) The medication records included both prescription and 
over-the-counter medications taken by patients in their homes and recorded by home care 
clinicians in their EHRs. Medication data included the medication names, doses, dose 
forms, frequencies and special instructions.  
2.1. Data Pre-Processing 
 HRMR scores were calculated for home healthcare patients based on three criteria 
that make up the composite measure: polypharmacy (the number of drugs they take), 
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Potentially Inappropriate Medications (PIM), and the Medication Regimen Complex 
Index (MRCI) that weighs drugs by the complexity of their dose forms or instructions. A 
separate study optimized the algorithm for calculating these criteria scores, primarily by 
adjusting the definition of polypharmacy to make it more sensitive to HRMR-related 
readmission risks. (Olson et al., 2014) 
 The OASIS data was pre-processed for the purpose of data mining following the 
same model and rules as a mobility outcome study that consisted of OASIS data for 
283,193 patients from 581 Medicare-certified home health care agencies.(Dey et al., ) 
Variables were removed if they had little or no variance or an excessive number of 
missing values. When two variables represented the same concept, such as the (1) 
presence and (2) number of Stage 1 pressure ulcers, only the less granular variable 
(presence of ulcer in this example) was retained.  All data were transformed to binary 
variables where continuous variables were mapped to discrete categories, and ordinal 
variables were mapped to two discrete categories indicating little or no problems versus 
moderate to severe problems. For example, the continuous variable for age was 
transformed to three age categories for patients ages 65 to 74, 75 to 85, and older than 85. 
An example of discretizing an ordinal value was a patient’s pain frequency, which is 
normally logged in OASIS code M0420 on a 0-3 scale. For this research, it was mapped 
to two binary categories: (0) little or no pain, and (1) moderate to severe pain. 
2.2. Methods  
 The pre-processed OASIS data was sorted into unsupervised clusters using the 
hierarchical agglomerative approach, which treats data points as individual clusters and 
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continuously merges them into larger clusters based on their similarity.(Blei, 2008) The 
Jaccard distance measure was used to determine the similarity of data points, and the 
average-linkage method was selected to create clusters based on the average distance of 
their data points from one another. Three other clustering techniques that analyze binary 
data were tested and applied to the OASIS data (hierarchical clustering using the 
complete-linkage method, and flat clustering use the k-means Hamming and k-means 
cosine methods) but ruled out for further analysis. A hierarchical approach can be less 
efficient and require more computations, but can produce more informative and 
interpretable results by creating a hierarchical structure that identifies relationships 
among the obtained clusters as well as the underlying data variables.(Manning, 
Raghavan, & Schutze, 2009) This was viewed as an appropriate choice for the study of a 
relatively small OASIS dataset, because hierarchical clustering can uncover relationships 
in patient characteristics that are novel but still relatable to clinicians in terms of what 
they see in their real-life home health care populations. The average-link method is more 
complex, but was preferred because it isn’t as crude as the complete-link method, which 
joins clusters by data points that are farthest apart. The complete method can fail to 
merge clusters that might have significant relationships(Blei, 2008; Milligan, 1980) due 
to being very conservative in computing the distance between the clusters, which results 
in many small clusters.(Pang-Ting, Steinbach, & Kumar, 2006) 
 Receiver Operating Characteristic (ROC) analysis was then applied to the patient 
subgroups produced by unsupervised clustering to determine if the HRMR algorithm is 
predictive of their rehospitalizations. ROC curves were generated for each of the HRMR 
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components (polypharmacy, PIM, and MRCI) for each subgroup. The area under the 
ROC curves (AUC) can be interpreted in this study as the probability of correctly 
predicting hospital readmission, based on sensitivity and specificity. The closer the AUC 
is to 1, the better the measure. An AUC curve between .7 and .9 is considered 
meaningful.(Tape, ) Results from the subgroups were then compared with the results for 
the overall population of 911 patients in the study group. 
 A test using the False Discovery Rate (FDR), a method of accounting for false 
positives in multiple-hypothesis research (Genovese, 2004), was then conducted to check 
the possibility that the subgroups’ AUC results were due to chance. Randomizing the 
headings of the demographic variables for the original OASIS patient data, 1,000 dummy 
patient groupings were created for each subgroup produced by unsupervised clustering. 
The patient numbers in each dummy group matched the number of patients in the actual 
clusters. ROC curves were then calculated for each dummy group in relation to the 
HRMR components, and used to estimate the probability that the results from the actual 
subgroups are false positives. For this study’s domain of a home healthcare patient 
population at medication-related risk for rehospitalization, an FDR rate of <.20 was pre-
selected to control the probability of false positives in the HRMR risk data. A literature 
review supported an FDR rate at this level as a threshold.(Charchar et al., 2012; 
Subramanian et al., 2005)  
3. Results 
 A heat map review of the hierarchical clustering results revealed six clusters of 
home healthcare patient groupings. The symmetrical map plotted the OASIS data on both 
   75 
 
 
the vertical and horizontal axis and created a diagonal line across the map where data 
variables were compared with themselves. Color coding of the map identified the size 
and strength of data clusters along the diagonal. (Figure 1) The dendrogram at the top of 
the map shows how agglomerative clustering merged characteristics of the 911 patients in 
the OASIS study group from the bottom up. 
 
Figure 1: Hierarchical Clustering Results for OASIS Study Population. 
Six blooms show clusters of patients formed from hierarchical analysis of their health 
status and demographic data in home health records. Names assigned by the authors to 
these clusters are below along with the OASIS data items that form the clusters. 
 
1: Good Functional Status 
OASIS codes: M0640-M0710 </= 7; M0720-M0770 </= 9 
2: Females in Moderate to Severe Pain  
OASIS codes: M0069 = 2; M0420-M0430 >/= 2 
3: Poor Prognosis Needing Functional Status Help 
OASIS codes: M0140 = 6; M0150 = 1 or 2; M0260 = 0; M0200 = 1; M0380 = 1 and 2 
4: Poor Functional Status 
OASIS codes: M0640-M0710 >/= 8; M0720-M0770 >/= 10 
5: Males with Adult Children as Caregiver 
OASIS codes: M0069 = 1; M0360 = 2 
6: Living Alone with Spouse as Primary Caregiver 
OASIS codes: M0360 = 1; M0340 = 1 
 Two of the clusters related solely to functional status, which is measured in the 
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OASIS data by patients’ relative abilities to complete activities of daily living (ADL), 
which include self-care tasks such as dressing or bathing, and instrumental activities of 
daily living (iADL), which include tasks for living independently such as housework and 
shopping.  
 Cluster 1, labeled Good Functional Status, reflected patients whose 
composite ADL scores (OASIS codes M0640-M0710) were lower than 
eight, and whose iADL scores (OASIS codes M0720-M0770) were lower 
than 10. Lower scores indicate that home health patients have more 
independent living skills.  
 Cluster 4 was labeled Poor Functional Status because it merged the 
opposite – patients with ADL scores of eight or higher, and iADL scores 
of 10 or higher – meaning they were in need of more assistance.  
 Cluster 2 produced a relationship between female home health patients 
(M0069 = 2) and those with moderate to high levels of pain. Pain level 
was determined by a composite score of 2 or greater for OASIS fields 
M0420 and M0430, which measure the frequency of pain and the presence 
of intractable pain, respectively.  
 Cluster 3 was the largest, merging the variables of patients who were 
white (M0140 = 6), received Medicare as their primary payer source 
(M0150 = 1 or 2), received assistance for ADLs and iADLs (M0360 = 1 
and 2), received a change in treatment plan with 14 days of OASIS 
assessment (M0200 = 1), and was diagnosed with a poor prognosis 
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(M0260 = 0). 
 Cluster 5 identified a relationship between home health patients who 
were male (M0069 = 1) and whose designated home health caregivers 
were their children (M0360 = 2).  
 Cluster 6 paradoxically associated home health care patients who live 
alone (M0340 = 1) with having their spouses as primary caregivers 
(M0360 = 1). 
 Overall hospital readmission rates varied by cluster; the highest rate was 41 percent 
in the Poor Functional Status group. Results also varied for how closely readmissions 
were tied to medication issues, as measured by the ROC curve analysis. (Table 1) 
 
Table 1: Patient Cluster Relationships to HRMR Components 
The rate of hospital readmissions among the clusters varied, as did the ROC analysis 
results indicating whether the clusters had relationships with medication-related 
predictors of readmission.  
Cluster 
ID 
Description Size % 
Readmitted 
Polypharmacy 
AUC 
PIM 
AUC 
MRCI 
AUC 
1 Good Functional Status 382 20% 0.68 0.58 0.69 
2 Females with Moderate 
to Severe Pain 
354 22% 0.7 0.64 0.68 
3 Poor Prognosis 
Needing Functional 
Status Help 
419 18% 0.68 0.59 0.68 
4 Poor Functional Status 287 41% 0.65 0.56 0.67 
5 Males with Adult 
Children as Caregiver 
197 27% 0.73 0.64 0.77 
6 Lives Alone with 
Spouse as Primary 
Caregiver (cluster does 
not make sense) 
206 3% 0.7 0.58 0.69 
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  **Entire OASIS Study 
Population 
911 20% 0.68 0.59 0.69 
 
 
 AUC results for all three medication-related components of HRMR were strongest 
for Cluster 5 – 197 men with adult children as caregivers – when compared to the results 
for the overall patient group. AUC curves of .73 and .78 for polypharmacy and MRCI, 
respectively, suggested these measurements were meaningful predictors of hospital 
readmissions within this patient subgroup. PIM had a weak predictive value (.64) for this 
patient cluster, but the AUC result was nonetheless stronger than it was for the overall 
patient population (.59). Cluster 5 also had the second-highest rate of patients who were 
readmitted to hospitals (27 percent). 
 Using FDR analysis, AUC results for the six groups produced by unsupervised 
clustering were compared to AUC results for randomized sample populations of the same 
sizes. (Table 2) The size of the clusters resulted in variations in FDR results, even when 
AUC results for the clusters were identical. This analysis supports the hypothesis that the 
males with adult children caregivers cluster was more strongly associated with HRMR-
related hospital readmissions. FDR rates in this subgroup met the study criteria of <=.20, 
indicating a hypothesis for future study. AUC results similarly improved when comparing 
medication-related readmission risks for the cluster of females with moderate to severe 
pain to the risks for the overall population of 911 home health care patients. However, the 
FDR results did not verify a strong relationship between this cluster and readmission 
risks. 
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Table 2: False Discovery Rate Analysis of Cluster Relationships to HRMR 
Components 
Testing whether the relationships between OASIS patient clusters and HRMR 
components were significant or possibly due to chance, the analysis validated the strength 
of the relationship for cluster 5. 
Cluster 
ID 
Description 
 
Polypharmacy 
FDR 
PIM 
FDR 
MRCI 
FDR 
1 Good Functional Status 0.41 0.5 0.43 
2 Females with Moderate to Severe Pain 0.30 0.22 0.50 
3 Poor Prognosis Needing Functional Status 
Help 
0.24 0.3 0.25 
4 Poor Functional Status 0.59 0.63 0.57 
5 Males with Adult Children as Caregiver 0.19 0.20 0.15 
6 Lives Alone with Spouse as Primary 
Caregiver (cluster does not make sense) 0.28 0.54 0.44 
 
 
4. Discussion 
 A challenge of unsupervised clustering and data mining in general is deciding 
which groups are meaningful. Human reasoning and theory-based interpretation can help 
but are limited because there is no statistical validation of these processes. This study 
used a valid test for finding clusters and determining through ROC and FDR analysis 
which ones met the threshold for interpretation. It also demonstrated that cluster analysis 
of OASIS data can identify subgroups of home healthcare patients, and that HRMR 
scores vary by clusters of patients compared to the overall population. 
Only one group met the threshold for having a statistical correlation with medication-
related hospital readmissions, and for further analysis and interpretation in this study. The 
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finding that a medication-related hospital readmission risk might be greater among 
elderly men with adult children as caregivers is novel, though other studies have found 
broader relationships between informal caregivers and medication-related problems. For 
example, changes or inconsistencies in the levels of care provided by informal caregivers, 
including adult children caring for their parents, can lead to difficulties in complying with 
prescription regimens and following complex dosing schedules and 
instructions.(Gillespie, Mullan, & Harrison, 2013) Further, struggles with medication 
compliance are linked with a high-percentage of medication-related visits to emergency 
departments,(Orwig, Brandt, & Gruber-Baldini, 2006) and hospitalizations among elderly 
adults whose assistance at home is insufficient.(Kuzuya et al., 2008) 
 There are several potential explanations for the relationship between HRMR scores 
and rehospitalizations for elderly men receiving assistance from their children. Adult 
children might find it difficult to manage medications for parents who want to maintain 
their autonomy, or create confusion as part-time caregivers if they oversee parents’ 
medications on some days, but not others. The latter would seem especially relevant in an 
era in which adult Baby Boomers do not view caring for their aging parents as a “natural” 
responsibility or one they can easily manage amid their own parenting and 
careers.(Guberman, Lavoie, Blein, & Olazabal, 2012) Caregiving situations in which 
siblings are caring for parents could also confuse the roles and responsibilities of 
medication management. 
 It is unclear whether informal caregiving itself is a cause of medication problems. 
One study found overdoses or missed doses were more common among elderly people 
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receiving informal medication support at home, but didn’t determine whether this support 
increased the risk of medication non-adherence or was merely associated with 
it.(Thiruchselvam et al., 2012) Another study found informal caregiving to have a 
positive relationship with adherence, as spouses or adult children helped people with 
chronic obstructive pulmonary disease stick to medication regimens and potentially avoid 
hospital readmissions.(Trivedi, Bryson, Udris, & Au, 2012)  
 Unsupervised clustering to identify patient groups by symptom combinations is 
emerging in literature. (Lee et al., 2010; Lewandowski, Sperry, Cohen, & Ongur, 2014; 
Moser et al., 2014; Wardenaar et al., 2014) Applying this approach specifically to OASIS 
data to identify patient subgroups by their demographic and health status information was 
novel, though not unprecedented.(Westra et al., 2011) The results suggested problems 
among specific subgroups of patients and informal caregivers that either aren’t well-
studied in research literature or have been studied inconclusively. The role of gender in 
medication issues such as non-adherence, for example, has been evaluated with varying 
results.(Granger et al., 2009; Holt et al., 2013; Pasina et al., 2014)  
 Our results suggested promising targets for future research: (1) identifying 
characteristics of adult children who are less reliable in helping their parents with 
medication management, and (2) uncovering risk factors that make elderly fathers more 
likely to experience medication-related hospital readmissions than mothers. More 
targeted research could also address whether a cause-and-effect relationship exists 
between family caregiving and an increased risk of medication-related hospital 
readmissions. With at least 75 percent of long-term care provided by family caregivers – 
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at an estimated value of $375 billion in unpaid labor(Gibson & Houser, 2007) – there is a 
great need to address their strengths and weaknesses and the dynamics of family 
caregiving that could lead to medication problems and hospital readmissions. 
4.1. Limitations 
 There are several limitations that should be considered in interpretation of this 
study. FDR’s broad handling of false positives and error rates allow for the discovery of 
associations that otherwise might go unseen. The FDR threshold in this study of .20 was 
supported by literature, but nonetheless was a judgment made by the researchers. 
Interpretations about medication management from a patient group in 2004 also need to 
be considered in light of health care reforms in the subsequent decade, including federal 
medication reconciliation requirements for hospitals to have electronic processes for 
verifying the safety and accuracy of patients’ prescription regimens. OASIS data 
interpretation could also affect the results of this study, as evidenced by the cluster of 
people paradoxically listed in the data as living alone at home but receiving care from 
spouses. More research using other methodologies is needed to verify the strength of the 
results. 
5. Conclusion 
 The unsupervised clustering combined with comparable literature results present an 
intriguing hypothesis that elderly men receiving care at home from their adult children 
are at elevated risk of medication-related hospital readmissions. The results also further 
research into HRMRs and their potential use in clinical systems to identify patients at risk 
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for avoidable readmissions. Future research opportunities presented by this study include 
exploration of the role of informal caregivers in managing or contributing to medication 
adherence issues, and further evaluation of HRMR in a different patient population to 
demonstrate its potential use as a clinical tool. More broadly, the success in one of the 
first attempts to apply clustering to OASIS data suggests other researchers could use this 
rich dataset to identify patterns in elderly patient care and health. 
   84 
 
 
 
 
 
 
 
 
 
Discussion and Conclusion 
 
 
 
 
 
 
 
 
 
 
 
   85 
 
 
1. Discussion 
 The three studies in this dissertation demonstrated that HRMR can be automated 
and potentially developed into a clinical support tool to predict hospital readmissions and 
identify patients who would benefit from support services that prevent readmissions. The 
algorithm for calculating HRMR scores from patients’ medication data was 
automated(Olson et al., 2014) and then optimized to improve its predictive accuracy and 
enhance its clinical utility.(Olson et al., 2014) Clustering analysis then identified a patient 
subgroup that had a greater HRMR-related risk for hospital readmission, presenting a 
hypothesis for future study and contributing to the emerging field of data mining using 
patient demographic and health care utilization databases. 
 1.1 Contributions to Informatics & Gaps in Literature 
 While increasing studies have individually investigated the concepts of 
polypharmacy,(Abdulraheem, 2013; Arnet, Abraham, Messerli, & Hersberger, 2013; 
Beloosesky et al., 2013; Hajjar et al., 2007; Morandi et al., 2013; Pasina et al., 2014; 
Sehgal et al., 2013; Sganga et al., 2014) PIM, (Baldoni et al., 2013; Bao, Shao, Bishop, 
Schackman, & Bruce, 2012; Fu et al., 2007; Price et al., 2014a; Price et al., 2014b; 
Sehgal et al., 2013; Vieira de Lima et al., 2013; Weng et al., 2013; Zhan et al., 2001) and 
MRCI(George et al., 2004; McDonald et al., 2013; Schoonover, 2011; Willson et al., 
2014; Wimmer et al., 2014), there has been no focus in published literature on the 
combination of these three drug-related indicators since an original HRMR study showed 
that these concepts together identify home health care patients who are at elevated risk of 
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hospital readmissions.(Dierich, 2010) All three studies produced as part of this 
dissertation are novel and address gaps in the health care literature in that they focus on 
this untested concept of the HRMR. The first study demonstrated that the manual concept 
of calculating HRMR could be automated, the second fine-tuned the underlying criteria 
for HRMR to optimize its predictive relationship with hospital readmissions, and the 
third used clustering techniques to examine subgroups in the sample population most 
susceptible to medication-related readmission risks. Beyond the results, the methods used 
to achieve them also contributed to the field of informatics by demonstrating their 
effectiveness as research tools. 
 The first study converted medication data into common RxNorm terminology, 
using crosswalks generated by APIs available on the National Library of Medicine web 
site, and was a key step in the proof of concept for HRMRs. The heterogeneous nature of 
medication records and prescription systems is a barrier to research and clinical analysis 
across health care systems.(Richesson, 2014) The standardization with RxNorm, which is 
considered “ideal” for such purposes,(Richesson et al., 2010) expedited the conversion of 
drug data into HRMR scores. This conversion made it possible for this novel approach of 
assessing readmission risks to be replicated by other clinicians or researchers. The APIs 
and crosswalks also allow researchers and clinicians to adapt and adjust the HRMR 
algorithm for future analysis and research.  
 However, while the conversion was ultimately successful, only 82 percent of the 
drug names were converted to RXCUI values without any manipulation of the data set 
that was used.(Olson et al., 2014) Conversion of 99 percent of the drug names required 
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some manual manipulation of the drug data due to misspellings or confusion over multi-
ingredient drugs. Analysis of drug data will be greatly enhanced and expedited by the 
continued adaptation of medication standards in EHR by hospitals and health systems. 
 The second study optimized the automated algorithm by using ROC curve analysis 
to test modified HRMR criteria against the original criteria used by Dierich.(Dierich, 
2010) The original manual HRMR study was based on clinical judgments, so the 
automation of the data presented an opportunity to test those judgments and determine if 
adjustments to HRMR scoring could improve the prediction of readmission risks. This 
further enhanced the clinical utility of the algorithm by improving its sensitivity to 
hospital readmission risks. The primary change from the optimization was the exclusion 
of vitamins and supplements for polypharmacy counts.(Olson et al., 2014) Other tests, 
such as removing acetaminophen from the algorithm, did not improve the ROC results. 
Widespread variations exist in the polypharmacy cut point used in previous 
studies(Hajjar et al., 2007) to distinguish patients with a low number of drugs versus 
those with a high number of drugs that puts them at risk for problems such as 
readmissions. This current study verified a cut point of 9 drugs as most effective in 
distinguishing patients’ hospital readmission risks. It also supported previous studies 
showing little to no correlation between readmissions and PIM medications 
alone.(Borenstein et al., 2013; Sehgal et al., 2013) The lack of any such connection is 
surprising, as it would seem intuitive that any elderly patients with drugs known to be 
risky would be at risk for complications that would require their returns to hospital care. 
The original MRCI criteria (George et al., 2004) from George et al. proved optimal for 
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predicting patients’ readmission risks, though adjustments based on an odds ratio analysis 
did modestly improve the predictive strength of Table C (drugs with special instructions). 
However, the MRCI cut point for separating patients by their readmission risk was 
increased to 33 from the original cut point of 20 used in the initial HRMR study.(Olson et 
al., 2014) Cut points produced by the analysis of the automated data could prove 
instructive as future researchers use these drug-related measurements.  
 The focus of the third study was on identifying patient subgroups that could 
potentially benefit from the clinical utility of the HRMR model. In theory, an EHR could 
identify patients by their characteristics – such as elderly males with adult child as 
caregivers – and flag clinicians of potential readmission risks. The results from the 
unsupervised clustering also offered a hypothesis that contributed to the literature 
showing the challenges of adult children and other informal caregivers caring for the 
elderly and managing their medications.(Gillespie et al., 2013; Kuzuya et al., 2008; 
Thiruchselvam et al., 2012) The results contributed to the evidence base for clinicians, 
who could discuss the potential for medication problems with informal caregivers and 
also consider this subgroup of elderly males with adult children as caregivers as 
candidates for additional support and home health services. The paper also reflects the 
novel and successful use of clustering to identify these patient groups within OASIS data. 
This rich dataset for home health patients could now be attractive to other researchers 
seeking to identify subgroups of patients by the demographics or health care utilization 
status. 
2. Limitations 
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 While providing proof of concept for HRMR and its potential utility as a clinical 
support tool, these studies could only go as far as one relatively small data set could carry 
them. The conversion of drug data into RxNorm terminology was necessitated by the 
older and somewhat crude methods of recording medication data. The data set lacked 
clear information about the 911 patients’ diagnoses. Authors reconstructed the most 
likely diagnoses of the patients based on the indications of the medications they were 
taking. While diagnoses were only relevant in analysis of PIM medications – to 
differentiate whether patients were taking drugs that had side effects related to certain 
conditions – the authors’ interpretations could have led to some errors in the results.  
Lastly, the lack of standards for special instructions and dose frequency resulted in 
limited automation from informatics coding standards to compute MRCI values. 
 Finally, the connection established between HRMR readmission risks and elderly 
patients with adult children as caregivers was validated using an FDR statistical method 
that is more liberal and is intended for the purpose of hypothesis generation. While there 
was research literature to suggest the connection was plausible, additional analysis is 
needed to prove it. 
3. Future Implications 
 The increasing adoption of EHRs – expedited in the last few years by government 
grants and mandates – has created new datasets and opportunities to analyze patient care 
trends and predict what types of patients are most likely to experience complications or 
adverse events. Research has grown rapidly in the area of analyzing secondary EHR data 
for patient care such as predicting the diagnosis of depression by mining diagnosis and 
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medication and clinical progress notes,(Huang et al., 2014) or earlier identification of 
heart failure patients through mining of signs and systems documented on encounter 
notes.(Vijayakrishnan et al., 2014) Analysis of patient medication data has been 
expedited by RxNorm, which is viewed as “ideal” for standardizing prescription 
data,(Richesson et al., 2010) and was used successfully to convert non-standardized 
medication records for the calculation of HRMR scores.(Olson et al., 2014)  RxNorm is 
being adopted directly by EHRs to support live recording of patients’ medication 
histories(Bennett, 2012). This presents opportunities for rapid calculation of patient 
HRMR scores and other medication metrics using EHR systems without any prior 
“normalization” of the medication data they contain. The construction of the HRMR 
model, and the ability to automate its calculation, present further opportunities for 
research, particularly with different patient populations and datasets to demonstrate the 
potential of HRMR as a clinical tool. Those opportunities include:   
 Larger and more recent OASIS and medication datasets. The original HRMR 
automation study was based on a home health care population of 911 patients. 
The tools and techniques, such as utilizing RxNorm APIs with SAS 
implementation, need to be tested on a larger dataset to determine if they remain 
efficient and effective at preparing medication data for analysis. Analyzing a 
larger patient population is also important to verify whether the relationship 
between HRMRs and hospital readmissions exists beyond the one population in 
the original study. The finding that a cluster of men with adult children as 
caregivers was more susceptible to medication-related readmission risks also 
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could be verified. And perhaps new clusters of clinically relevant home health 
care populations could emerge from data mining of a larger OASIS dataset.  
 Other clinical EHR datasets. While OASIS is valuable for the clinical and 
demographic information it contains, it is limited to the population of home 
healthcare patients. As EHR datasets become more robust and formatted for 
secondary research, the opportunity arises to test the predictive power of HRMR 
on a broader range of ages and demographics. Testing the automated HRMR 
algorithm on a broader population is important, because it is possible that HRMR 
only has a predictive quality for hospital readmissions in the home health care or 
elderly population. It is also possible that the cut points for the HRMR 
components such as polypharmacy (the number of drugs that separate patients by 
their risk levels) will be different in a broader population. As a result, HRMR 
might be clinically useful but will need to be adjusted based on demographic 
factors to assess hospital readmission risks. And just as data mining found a 
unique subgroup of patients within an OASIS dataset, this same clustering 
research might identify high-risk groups within the broader population. Studies, 
for example, already point to medication adherence and mental illness as 
indicators of readmission.(Haddad, Brain, & Scott, 2014) Other variables that 
might be analyzed within an EHR dataset include social history (tobacco use, 
illegal drug use, sexual activity, etc.), vitals (height, weight, BMI, blood 
pressure), allergies, immunizations, orders (lab, radiology, etc.) and problem lists. 
EHRs are currently used to flag clinicians when patients appear at risk of 
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depression and heart failure; it is certainly possible that HRMR tracking could be 
integrated into these systems to similarly flag clinicians about patients with 
medication-related risks for hospital readmissions. 
 Medical and Pharmacy Claims data. Similarly, follow-up studies could explore 
whether claims databases could efficiently and effectively yield HRMR scores of 
patients. The size of public or private insurance claims databases – spanning 
across health care providers and systems – could help provide important 
validation for the relationship between HRMR and hospital readmission risk. 
Claims databases could also expand the analysis of HRMRs to determine whether 
they are more likely among patients with higher personal costs of care, or among 
patients with different types of health insurance (HMO, PPO, etc.) They could 
also allow for comparisons in terms of the net cost of patients – comparing those 
who meet the threshold for HRMRs and those who do not. Given that patients 
with high risk medication regimens are more likely to be rehospitalized, it would 
seem possible that they would cost more than patients with lower medication 
usage who don’t meet that threshold. Applying the automated HRMR calculations 
to claims databases could prove or disprove that assumption. 
4. Conclusion 
 Applying the automated algorithm to diverse datasets is crucial to validating and 
optimizing the clinical utility of HRMR calculations, and to identifying the types of 
patients for whom HRMR is a more meaningful predictor of hospital readmissions. The 
overall goal of the study demonstrated that HRMR can be automated as a clinical support 
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tool to enhance patient care – and demonstrates ripple effects that point to new directions 
for research. 
 A valid, automated method for deriving HRMR scores from EHRs could compel 
other researchers to use the method and to further evaluate using these scores as clinical 
tools. Secondary analysis has the potential – as revealed by the third study – to uncover 
multiple relationships between patients’ HRMR scores and their health outcomes as 
measured by the OASIS and EHR data. The clustering analysis offered new targets for 
researchers to explore further in their efforts to understand the linked roles of medication, 
medical interventions and the health and outcomes.   
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Appendix A 
 
Potentially Inappropriate Medications  
Potentially Inappropriate Medications: Independent of Diagnoses or Conditions, 
from Fick et al. (2003, p. 2719), used with permission. 
Drug/Drug Combinations with the Active Ingredient Low 
Risk 
High 
Risk 
Propoxyphene (Darvon) X  
Indomethacin (Indocin)  X 
Pentazocine (Talwin)  X 
Muscle relaxants and antispasmodics: methocarbamol (Robaxin), 
carisoprodol (Soma), chlorzoxazone (Paraflex), metaxalone 
(Skelaxin), cyclobenzaprine (Flexeril), and oxybutynin (Ditropan). Do 
not consider the extended-release Ditropan XL. 
 X 
Flurazepam (Dalmane)  X 
Amitriptyline (Elavil), chlordiazepoxide-amitriptyline (Limbitrol), and 
perphenazine-amitriptyline (Triavil) 
 X 
Doxepin (Sinequan)  X 
Meprobamate (Miltown and Equanil)  X 
Doses of short-acting benzodiazepines: doses greater than lorazepam 
(Ativan), 3 mg; oxazepam (Serax), 60 mg; alprazolam (Xanax), 2 mg; 
temazepam (Restoril), 15 mg; and triazolam (Halcion), 0.25 mg 
 X 
Long-acting benzodiazepines: chlordiazepoxide (Librium), 
chlordiazepoxide-amitriptyline (Limbitrol), clidinium-
chlordiazepoxide (Librax), diazepam (Valium), quazepam (Doral), 
 X 
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halazepam (Paxipam), and chlorazepate (Tranxene) 
Disopyramide (Norpace and Norpace CR)  X 
Digoxin (Lanoxin) (should not exceed _0.125 mg/d except when 
treating atrial arrhythmias) 
X  
Short-acting dipyridamole (Persantine). Do not consider the long-
acting dipyridamole (which has better properties than the short-acting 
in older adults) except with patients with artificial heart valves 
X  
Methyldopa (Aldomet) and methyldopa-hydrochlorothiazide (Aldoril)  X 
Reserpine at doses > 0.25 mg X  
Chlorpropamide (Diabinese)  X 
Gastrointestinal antispasmodic drugs: dicyclomine (Bentyl), 
hyoscyamine (Levsin and Levsinex), propantheline (Pro-Banthine), 
belladonna alkaloids (Donnatal and others), and clidinium-
chlordiazepoxide (Librax) 
 X 
Anticholinergics and antihistamines: chlorpheniramine (Chlor-
Trimeton), diphenhydramine (Benadryl), hydroxyzine (Vistaril and 
Atarax), cyproheptadine (Periactin), promethazine (Phenergan), 
tripelennamine, dexchlorpheniramine (Polaramine) 
 X 
Diphenhydramine (Benadryl)  X 
Ergot mesyloids (Hydergine) and cyclandelate (Cyclospasmol) X  
Ferrous sulfate >325 mg/d X  
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All barbiturates (except phenobarbital) except when used to control 
seizures 
 X 
Meperidine (Demerol)  X 
Ticlopidine (Ticlid)  X 
Ketorolac (Toradol)  X 
Amphetamines and anorexic agents  X 
Long-term use of full-dosage, longer half-life, non–COX-selective 
NSAIDs: naproxen (Naprosyn, Avaprox, and Aleve), oxaprozin 
(Daypro), and piroxicam (Feldene) 
 X 
Daily fluoxetine (Prozac)  X 
Long-term use of stimulant laxatives: bisacodyl (Dulcolax), cascara 
sagrada, and Neoloid except in the presence of opiate analgesic use 
 X 
Amiodarone (Cordarone)  X 
Orphenadrine (Norflex)  X 
Guanethidine (Ismelin)  X 
Guanadrel (Hylorel)  X 
Cyclandelate (Cyclospasmol) X  
Isoxsurpine (Vasodilan) X  
Nitrofurantoin (Macrodantin)  X 
Doxazosin (Cardura) X  
Methyltestosterone (Android, Virilon, and Testrad)  X 
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Thioridazine (Mellaril)  X 
Mesoridazine (Serentil)  X 
Short acting nifedipine (Procardia and Adalat)  X 
Clonidine (Catapres) X  
Mineral oil  X 
Cimetidine (Tagamet) X  
Ethacrynic acid (Edecrin) X  
Desiccated thyroid  X 
Amphetamines (excluding methylphenidate hydrochloride and 
anorexics) 
 X 
Estrogens only (oral) X  
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Appendix B  
 
Medication Regimen Complexity Index 
The Medication Regimen Complexity Index, Section A (George et al., 2004, p. 1374), 
used with permission. 
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The Medication Regimen Complexity Index, Sections B and C (George et al., 2004, 
p. 1375), used with permission. 
 
 
 
 
 
 
 
 
 
 
 
